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Three series of experiments were conducted to: 1) optimize the conditions for the 
production of pUC19 plasmid and of biotinylated pUC19 fragments; 2) optimize the 
conditions for the production of protein A-streptavidin chimera (chimeric protein); and 3) 
detect soluble antigens [bovine serum albumin (BSA) and interleukin-6 (IL-6)] and 
membrane-bound antigens [insulin receptor and epidermal growth factor receptor 
(EGFr)] of mouse embryos by immuno-polymerase chain reaction (I-PCR). 
The first experimental series, which included bacterial culture, chimeric protein 
purification, and chimeric protein functional experiments, was performed to investigate 
the effects of IPTG (isopropyl-P-D-thiogalactopyranoside) induction time and 
temperature, bacterial culture medium, and protein purification procedure on chimeric 
protein yield. The yield of chimeric protein was affected by IPTG induction time, but not 
by induction temperature. The yield of chimeric protein from TB broth culture was five 
to ten times higher than from either M9 or LB medium culture. Eliminating a 
centrifugation step just before the biotin affinity chromatography increased the yield of 
chimeric protein three times more than when the centrihgation step was included. Data 
demonstrated that our chimeric protein was fully hnctional. 
The second series, including culturing and biotinylation experiments, was 
conducted to investigate the effects of culture conditions [Lennox L broth (LB broth) 
versus Terrific broth (TB broth) and 15 versus 28 hours] on pUC19 plasmid yield from 
pUC19 plasmid-transformed Escherichia coli (E. coli), and the effect of incubation 
conditions on the efficiency of pUC19 biotinylation. Culture medium but not culture time 
affected pUC19 plasmid yield. pUC19 biotinylation at 37 "C for 30 min seemed to be 
superior compared to 15 min either on ice or at room temperature. Data demonstrated that 
biotinylated pUC19 fragments were hlly hnctional. 
The third series, including BSA, IL-6, insulin receptor, and EGFr assays, was 
performed using I-PCR and enzyme-linked immunosorbent assay (ELISA) assays to 
determine the absolute sensitivity of I-PCR technique and to compare the relative 
sensitivity between I-PCR and ELISA for detecting these antigens. The sensitivity limits 
of I-PCR were 5.8 BSA and 5.8 x lo3 IL-6 molecules immobilized on the surface of 
a microtiter plate, which were six and seven orders of magnitude more sensitive than 
ELISA, respectively. By using I-PCR technique, we were able to detect insulin receptors 
on two mouse embryos and EGFr on only one mouse embryo at the morula stage. Data 
from these studies should be valuable for the fbture development of a non-invasive, 
I-PCR-based assay of individual embryo viability. 
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Chapter 1 
IMMUNO-POLYMERASE CHAIN REACTION AND ITS POTENTIAL USE KN 
EMBRYO VIABILITY ASSAY 
Ultra-Sensitive Detection of Membrane-Bound and Soluble Antieens bv Immuno- 
Polvmerase Chain Reaction 
The A~~ l i ca t ion  of Immuno-Polvmerase Chain Reaction 
A new antigen detection technique named Immuno-Polymerase Chain Reaction 
(Immuno-PCR) was developed within the past decade. The term, Immuno-PCR, can be 
dated back to 1991 (Widjojoatmodjo et al., 1991). In that year, a research group in 
the Netherlands used monoclonal antibodies to trap Salmonella onto magnetic particles 
and used the PCR technique to amplify a particular sequence of bacterial DNA with 
primers from the Salmonella typhimuriun origin of DNA replication. The PCR products 
were visualized either by ethidium bromide-stained agarose gel or by Southern blotting. 
This new technique was called the Magnetic Immuno-PCR Assay (MIPA). A year later, 
another research group (Sano et al., 1992) detected bovine serum albumin (BSA) with 
a similar system. With this system, BSA molecules were immobilized onto the surfaces 
of wells of a microtiter plate. Anti-BSA immunoglobulin G (IgG) was subsequently 
allowed to interact with the plate-bound BSA molecule. Finally a linker molecule 
(a fkion protein), which contained both protein A and streptavidin moieties, was 
introduced and allowed to attach to the Fc portion of the IgG molecule with the protein A 
side and the biotin portion of a biotinylated DNA molecule with the streptavidin side. 
The marker DNA was used to generate PCR products and the products were visualized 
by ethidium bromide-stained agarose gel. Sano's group called this antigen detection 
system Irnmuno-Polymerase Chain Reaction or Irnmuno-PCR, which is the most 
commonly used term today. 
The three basic components of an Immuno-Polymerase Chain Reaction (referred 
to I-PCR thereafter) assay are the antigen recognition system, the marker DNA 
amplification system, and the signal manifestation system. The antigen recognition 
system contains the target antigen, an antibody which is specific to the antigen, and 
a DNA molecule (marker DNA) that is linked to the antibody indirectly through a linker 
molecule, or directly through antibody-DNA conjugation. The antigen recognition 
system in an I-PCR is based on the same format as ELISA and RIA (radioimmuno- 
assays). The only difference among them is that an enzyme in ELISA or an isotope in 
RIA is replaced by a piece of DNA in I-PCR. I-PCR is the most sensitive antibody-based 
antigen detection system presently available since it combines the high specificity of 
antibody and antigen interaction with the high sensitivity of polymerase chain reaction 
(PCR). This combination makes it the most powehl  tool to date for detecting minute 
amount of antigens. In principle, this technique could be used to detect a single antigen 
molecule. 
Since I-PCR was first described, it has been extensively used to detect a variety of 
antigens, including both membrane-bound and soluble antigens, with tremendous 
improvements in sensitivity and efficiency compared to other commonly used assay 
methods. Like all other techniques, I-PCR has been subjected to modifications and 
refinement during its development due to the cooperative efforts of scientists worldwide. 
Detection of Membrane-Bound Antigens. Although I-PCR has been used to detect 
membrane-bound antigens on different cell types, including both eukaryote and 
prokaryotic cells, the general body of information on cellular I-PCR is relatively small 
compared to I-PCR of soluble antigens. The ability of I-PCR to detect membrane-bound 
antigens on samples of small number of cells has a great significance, because these 
antigens are usually undetectable, or are very difficult to detect with traditional assay 
methods, such as ELISA. All the data generated so far demonstrate that I-PCR is very 
useful for detecting these membrane-bound antigens. 
Detection of Membrane-Bound Antigens on Eukaryote Cells. Little data are 
available pertaining to the detection of membrane-bound antigens on eukaryote cells. 
Even fewer data are available on the detection of membrane-bound antigens on embryos. 
Only a few papers have been published dealing with I-PCR for detecting antigens on 
embryos and all the data were generated from the same research group at Northeastern 
University. McElhinny and Warner (1997) were the first to use I-PCR on mammalian 
embryos when they reported the use of I-PCR to detect major histocompatibility complex 
class I (H-2 Db) molecules on murine blastocysts. They were able to detect signal on one 
mouse blastocyst. In contrast, more than 15 mouse blastocysts were needed in order to 
obtain a positive H-2 Db signal by ELISA. Using the same technique, McEIhinny et al. 
(1998) successfully detected Qa-2 antigens not only on whole mouse embryos but also on 
isolated inner cell mass (ICM) cells. Wu et aL(1999) from the same lab microinjected 
Q7 and Q9 genes (which encode for the Qa-2 antigen) into Ped (preimplantation 
embryonic development)-slaw mouse zygotes (Qa-2 negative), and could detect Qa-2 
protein expression on a single microinjected embryo at the blastocyst stage by I-PCR. 
Ke and Warner (2000) also introduced Q7 and Q9 genes into the male pronucleus of 
1 cell F1 Ped slow embryos through microinjection, and the protein expression of the 
injected gene was detected on 15 pooled one-cell mouse embryos by I-PCR. 
McEIhinny et al. (2000) attempted to incorporate Qa-2 antigens onto the surface of 
Ped slow preimplantation mouse embryos through a process called protein "painting", 
and subsequently detected the painted Qa-2 molecules on a single Ped slow 
preimplantation embryo. In addition to mouse embryos, I-PCR has also been used to 
detect membrane-bound antigens on other cell types including the gastric cancer- 
associated antigens on the cell line KATO I11 (Ren et al., 1994), and carbohydrate tumor- 
antigens on cancer cells (Zhang et al., 1998) with a detection limit of less than10 cells. 
Detection of Membrane-Bound Antigens on Prokaryote Cells. Widjojoatmodjo et 
al. (1991) pioneered the detection of antigens on prokaryote cells by a technique called 
the Magnetic Immuno-PCR Assay (MIPA). With MIPA, one hundred colony forming 
units (CFU) of Salmonella typhimurium were detectable by visualization of the amplified 
products by ethidium bromide-stained agarose gel electrophoresis. The same technique 
was also used to detect Salmonellae at 10' CFUImL in human fecal samples 
(Widjojoatmodjo et al., 1992). The results indicated that using MIPA not only improved 
detection sensitivity, but also significantly reduced the work needed to dilute fecal 
samples for detection. With primers specific for the iroB gene common to all strains of 
Salmonella enteridica, Salmonella enteridica and other bacterial species could be 
distinguished by using MIPA (Baumler et al., 1997). 
Wolfhagen et a1.(1994) also used MIPA to detect toxigenic Clostridium dzflcile in fecal 
samples. Using a monoclonal antibody (MAb), specific for Clostridium drfJicile, 
Clostridium sordellii, and Clostridium bifermentans, these researchers achieved 
a sensitivity of 96.7%, and specificity of 100% without elaborate extraction of DNA fiom 
fecal samples. They concluded that this method was rapid, easy, and sensitive for 
detecting the presence of toxigenic C. dzflcile in stool samples. Kakizaki et al. (1996) 
used I-PCR to detect the pathogenic bacteria, Pasteurella piscicida. Immuno-polymerase 
chain reaction could detect as little as 3.4 CFUImL of bacteria, whereas ELISA's limit of 
detection was much higher (3.4 x lo4 CFUImL). 
Leptospires in urine samples of 10 experimentally infected cattle were 
consistently detected by MIPA (Taylor et al., 1997), and the results indicated that 
the immunomagnetic separation of leptospires from inhibitors in frozen formalin-fixed 
bovine urine prior to PCR detection significantly improved both sensitivity and speed. 
Giardia in environmental water were also detected by I-PCR (Mahbubani et al., 1998). 
It was claimed that the reliability for detection of this pathogen with the required 
sensitivity was improved by using I-PCR. 
The pathogenic bacteria Escherichia coli (E. coli) 01 57:H7 in both contaminated 
dairy products and ground beef samples was detected using I-PCR (Ogunjimi and 
Choudary, 1999). Results were obtained within eight h with detection sensitivities 
approaching one CFUIg or mL. The authors concluded that this method was suitable 
for rapid screening of E. coli 0 157:H7 in fruit juices and plant produce. 
Cao et al. (2000) used in situ I-PCR to detect hepatitis B viral antigens in hepatic 
tissues. In this research, amplified DNA sequences were detected in situ by hybridization 
with digoxigenin-labelled DNA probe followed by immuno-staining. Paraffin sections of 
liver samples fiom patients with hepatitis B virus (HBV) infection were examined for 
HBsAg expression by in situ I-PCR. It was concluded that in situ I-PCR might be the 
only technique available to detect minute quantities of biological macromolecules such as 
proteins, carbohydrates, and lipids in intact cells or tissue sections. 
I-PCR was compared with other assays in detecting nonstructural protein (NS I), 
a common antigen among influenza A viruses (Ozaki et al., 2001). The sensitivity was 10 
to 100 times higher with I-PCR than that with RT-PCR for the detection of the viral 
genome. Using anti-hemagglutinin (HA) monoclonal antibodies to detect HA subtype- 
specific antigen, the sensitivity was up to times higher than by virus isolation or by 
RT-PCR. 
Detection of Soluble Antipens. Soluble antigens must be immobilized first in order to 
be detected. The most common method for immobilization is to bind the antigens onto 
the surface of a solid support, such as the surface of the wells of a 96-well plate. 
Immobilization may be achieved directly through electro-magnetic interactions, or 
indirectly through the action of a capturing antibody coated onto the solid support. 
Detection of Antigens Immobilized Directly onto a Solid Support. The first 
attempt to detect the soluble antigens immobilized directly onto the surface of solid 
support by I-PCR was reported by Sano et al. (1992). The antigen to be detected was 
BSA which was immobilized on the surface of wells of a 96-well plate. A piece of 
biotinylated-pUC19 molecule was indirectly linked to an anti-BSA IgG by a protein A- 
streptavidin chimera (linker molecule). The signal was generated by amplifying a 
segment of pUC19 molecule by PCR. The PCR products were detected by agarose gel 
electrophoresis with ethidium bromide staining. The results revealed that I-PCR 
improved detection sensitivity about lo5 times over ELISA. Ruzicka et al. (1993), who 
simplified Sano's chimeric protein-based method by using all reagents from commercial 
sources, were still able to detect as little as 10 fg of anti-apolipoprotein E per milliliter of 
coating solution. 
A full-length recombinant human proto-oncogene (ETS 1) was detected by using 
I-PCR (Zhou, 1993). In Zhou's I-PCR assay, the antigen, ETS 1, was coated onto ultra 
thin-wall PCR tubes overnight at 4 "C to immobilize the antigen. Then purified ETS1- 
specific monoclonal antibody, biotinylated sheep anti-mouse secondary antibody, free 
streptavidin, and biotinylated EcoRI-digested paTEL14 (marker DNA) were added 
sequentially. The immobilized linear DNA was subjected to PCR amplification. Signal 
from ETSl could be detected with as few as -5.8 x lo3 molecules. 
Bovine herpesvirus 1 (BHV-1) antigens were detected by I-PCR after 
immobilization on microtiter plates (Mweene et al., 1996). BHV-1-specific monoclonal 
antibody, biotin-labeled goat anti-mouse antibody, streptavidin, and biotin-labeled 
marker DNA were added sequentially, with washes after each step. The plates were 
subjected to PCR and an agarose gel was used to detect the amplified PCR products. 
A sensitivity of up to lo7 higher than that of ELISA for antigen detection was obtained. 
I-PCR was also demonstrated to be very useful for detecting BHV-1 in the nasal 
secretions and various tissues of experimentally infected calves (Mweene et al., 1996). 
The application of a single I-PCR protocol for the detection of multiple antigens 
was studied by Case and colleagues (1997, 1999). These antigens were diverse both in 
chemical structure and size: ~~-rneth~lguanosine conjugated to BSA (o~-M~G-BsA, 
Mr 6.76 x lo4), pyruvate dehydrogenase complex (PDC) oligomer (Mr 8.5 x lo6), 
~ ~ - m e t h ~ l g u a n i n e - ~ ~ ~  methyltransferase (MGMT) monomer (Mr 2.17 x 1 04), and an 
N-terminal oligopeptide of MGMT (Mr 2.3 1 x lo3). The detection limits were between 
180 and 6.9 x lo7 molecules, with O ~ - M ~ G  and PDC to be the most sensitive and MGMT 
to be the least sensitive. 
Human serum gastric carcinoma-associated antigen MG7-Ag was detected after 
immobilization on the surface of microtiter plate wells (Ren et al., 2000). It was 
concluded that this technique could be applied in the clinical setting readily and could be 
a potential screening tool in mass surveys of high-risk populations with gastric 
carcinoma. 
Another variant of I-PCR, called immuno-detection amplified by T7 RNA 
polymerase (IDAT), has recently been described (Zhang et al., 2001). With this 
technique, a double-stranded oligonucleotide containing the T7 promoter was 
conjugated to an antibody, and then the T7 RNA polymerase was used to amplify RNA 
from the double-stranded oligonucleotides coupled to the antibody in the antibody- 
antigen complex. This technique was lo9- fold more sensitive than the conventional 
ELISA method for detecting the p185 (her2lneu) receptor on T6-17 cells. The 
researchers claimed that this technique was capable of monitoring proteins, lipids, 
metabolites, and their modifications at the single-cell level. They also claimed that 
IDAT represented a significant improvement over conventional I-PCR in terms of 
sensitivity. 
Clostridium botulinum neurotoxin type A (BTx-A) was assayed recently with 
I-PCR technique (Wu et al., 2001). A murine monoclonal antibody against BTx-A was 
covalently coupled to double-stranded marker DNA using a heterobifhctional cross- 
linker reagent. A dose-dependent relationship was demonstrated. Detection sensitivity 
of I-PCR for BTx-A (3.33 x 10-l7 moles) exceeded that of the conventional ELISA 
(3.33 x 10-l4 moles) by 1000-fold. The DNA-antibody conjugates can be used to detect 
BTx-A antigen directly, without the addition of biotinylated reagents, binding proteins, 
and numerous washing steps. Such a simplified I-PCR technique may prove valuable for 
antigen detection in clinical diagnosis. 
Detection of Antigens Indirectly Immobilized onto the Surface of a Solid Support 
by a Capture Antibody. A sandwich is generally used to perform this type of assay. 
In a sandwich format, an antibody against a target antigen is bound to the surface of 
a solid support. Antigen is allowed to bind to coated antibody, then a second antibody 
against a different epitope on the antigen binds to the immobilized antigen. The second 
antibody is linked to a reporter molecule, such as an isotope, enzyme, or a marker DNA. 
Because the Hepatitis B virus (HBV) antigen in serum is undetectable by currently 
available immunoassays, Maia et al. (1995) tried to use an I-PCR sandwich assay to 
detect this antigen in serum. The two antibodies chosen were high affinity anti-HBV 
monoclonal antibodies directed against distinct and separate determinants on the HBV 
antigen. After the antigen was captured by the first (coated) antibody, the second 
antibody (biotinylated) was allowed to bind to captured antigen. This step was followed 
by the addition of free streptavidin. Finally, a biotinylated linear DNA molecule derived 
fiom a bluetongue virus (BTV) gene was allowed to bind to the fiee binding site 
on the capture streptavidin. PCR was conducted on the bound marker DNA with BTV- 
specific primers. As little as 0.5 pg of hepatitis B surface antigen (HbsAg) in a serum 
sample could be detected. 
The I-PCR assay has been used to detect two clinical analytes, human thyroid- 
stimulating hormone (hTSH), and human chorionic gonadotropin (hCG) (Goerger et al., 
1995). DNA-antibody conjugates were generated by using heterobifunctional cross- 
linker chemistries. These approaches yielded molecular chimeras both for analyte 
binding and PCR amplification. Dose-response relationships were observed for I-PCR 
assays of both analytes. Detection limits for hTSH and hCG were 1 x 10-l9 and 
5 x 10-l7 M, respectively. These sensitivities exceeded those of conventional ELISA by 
three to four orders of magnitude. 
I-PCR has also been used to detect tumor necrosis factor alpha (TNF-alpha). 
Sanna et al. (1995) investigated the time course of TNF-alpha induction in rat 
cerebrospinal fluid after intracerebroventricular administration of bacterial 
lipopolysaccharide (LPS). I-PCR sensitivity was 0.625 pg/well and the sensitivity of the 
ELISA version of the same assay was 100 pg/mL (159 -fold difference in sensitivity). 
Due to the high sensitivity of I-PCR, TNF-alpha in the cerebrospinal fluid could be 
detected as early as 15 min after LPS administration. 
TNF-alpha cannot be measured in human serum by existing methods other than 
I-PCR due to its low concentration. However, it has been detected by I-PCR (Saito et al., 
1999). The detection limit of this assay was 0.00 1 ng/mL, an approximately 5 x 1 o4 fold 
improvement compared to a conventional ELISA. 
The sensitivity of I-PCR was compared to that of ELISA for detecting soluble 
murine T cell receptors (sTCR) (Sper et al., 1995). With the direct ELISA employing 
hamster anti-TCR beta monoclonal antibody (which detects all types of alpha and beta 
TCR) the detection limit was 6000 pg/mL; with the indirect sandwith ELISA using 
anti-V beta 8 as capture antibody, the detection limit was 600 pg/mL; with ELISA using 
anti-V beta 8, the detection limit was 100 pg/mL; and with I-PCR assay, the detection 
limit was 0.8 pg/mL. 
Simultaneous detection of multiple antigens in solution by a single PCR reaction 
was also possible with I-PCR. Three analytes (hTSH, hCG and P-Gal) were detected 
in a single reaction (Hendrickson et al., 1995). Assays were performed using 
a two-antibody sandwich assay. With this system, three marker DNAs, different in 
length (55, 85, and 99 bp), were covalently attached to three different second antibodies. 
These DNA sequences were identical at 5' end and at 3' end, so that a single primer pair 
could be used to amplify the three marker DNAs to generate 55, 85, and 99 bp products. 
Analytes were detected at sensitivities exceeding those of ELISA assays by 
approximately three orders of magnitude. Detection limits for hTSH, hCG, and P-Gal 
were 1 x10-19, 1 x 10-17, and 1 x 10-l7 moles, respectively. 
Suzuki et al. (1995) detected soluble intercellular adhesion molecule-1 (SICAM-1) 
from Panc-1 cells using I-PCR, with a detection limit lo3 times higher than that achieved 
by ELISA. I-PCR was also used to detect this antigen in sera at a level below the 
detection limit of traditional ELISA. 
An I-PCR sandwich assay was used to detect a-atrial natriuretic peptide (ANP) 
in human plasma (Numata and Matsumoto, 1997). ANP is a 28-amino acid polypeptide 
with an intermolecular disulfide bridge that is synthesized mainly in the heart atria. 
Plasma ANP levels are increased in patients with heart failure, therefore, they serve as 
good indicators of atrial distension in these patients. It usually takes 2 or 3 days after 
heart damage to quantifj plasma ANP by immunoradiometric assay (Yamauchi et al., 
1991) or ELISA (Hashida et al., 1988) because of its very low concentration in plasma, 
but using I-PCR sandwich assay, one can quanti@ plasma ANP within five h of initial 
heart damage. The lowest level of ANP detected by I-PCR was 2.0 ng/L (50 fg per tube). 
Chang and Huang (1997) used I-PCR to detect E. coli beta-glucuronidase (GUD). 
The surface of 96 V-bottomed polycarbonate microtiter plate wells were coated with 
the first anti-GUD antibody (rabbit anti-GUD antibody). Then GUD molecules were 
added to the wells and were captured by the first antibody. This was followed by adding 
biotinylated second anti-GUD antibody bound to a different epitope on the captured GUD 
molecule. The biotin group was allowed to interact with the avidin molecule on avidin- 
biotinylated h phage DNA. Amplification of this DNA fragment generated 500 bp PCR 
products. The detection limit was 1 x lop1' g/mL (or 5 x 10-l9 dwell), which was 
equivalent to two GUD molecules in 50 microliters of a sample solution. This technique 
was so sensitive that it could detect the enzymes released from a single E. coli cell 
in a solution of 10 L. 
Furuya et al. (Furuya et al., 2000) used an I-PCR sandwich assay to detect human 
interleukin- 18 (IL- 18) in serum, where the concentration in patients with acquired 
immunodeficiency syndrome (AIDS) was too low to be measured accurately with 
conventional ELISA. The plate was coated with mouse anti-human IL-18 monoclonal 
antibody, followed by sequential addition of IL-18 antigen, rabbit polyclonal anti-human 
IL- 18 antibody, and biotinylated goat F(abt)2 anti-rabbit IgG to each well. After 
washings between steps, free streptavidin was added to each well. Finally, 50 pl of 
biotinylated DNA was added and this marker DNA was replicated by PCR. With I-PCR 
assay, the detection limit was 2.5 pdliter, 1.6 x lo4 times more sensitive than that of 
ELISA. The authors claimed that this I-PCR for human IL-18 was the most sensitive 
method for detecting human IL-18 reported to date. 
Sugawara et al. (2000) used I-PCR assay to detect human recombinant 
angiotensinogen using identical first and second polyclonal antibodies. A rabbit 
polyclonal antibody (first PAb) immobilized on an ELISA microtiter plate was used to 
capture antigen sandwiched with biotinylated rabbit polyclonal antibody (second PAb), 
after which streptavidin was added. Biotinylated DNA (which was initially generated by 
PCR amplification using a biotinylated primer) was then allowed to bind to plate-bound 
streptavidin. Finally, the marker DNA was amplified through PCR. The detection limit 
was 0.1 ng/L, an approximately 2.5 x lo5 fold improvement compared to a conventional 
ELISA assay. 
I-PCR Components and I-PCR Assay Sensitivitv 
The First Antibody. The first antibodies are the molecules that make direct contact with 
target antigens. Their physical properties have a great impact on the sensitivity and 
selectivity of I-PCR assays. Both monoclonal (Wolflagen et a1.1994, Numata and 
Matsumoto, 1997) and polyclonal (Case et al., 1997) antibodies can be used in I-PCR 
assays. The concentration used depends the antibody chosen and the user's preference. 
McElhinny and Warner (1997) used a high concentration (500 pg/mL) of a n t i - ~ - 2 ~ ~  
antibody to detect major histocompatibility complex Class I antigens on the surface of 
murine embryos. In contrast, Zhang et al. (1998) found that less than one ng/mL of DNA- 
HurnAb complex was required to detect carbohydrate tumor-antigens on tumor cells. 
Case et al. (1999) demonstrated that, as the concentration of polyclonal antibodies was 
increased fkom one pg/mL to ten pg/mL, assay sensitivity increased 100-fold. One of the 
major factors affecting antigen detection limits is primary antibody titers. Case et al. 
(1 999) showed that antigen detection limits were positively correlated with primary 
antibody titers and antigen molecular weight did not affect the sensitivity of I-PCR. 
Linker Molecule. Several techniques are available for linking antibodies to DNA 
molecules. Sano et al. (1992) used a protein A-streptavidin chimera to link protein A- 
compatible IgG molecules to biotinylated DNA n~olecules. Streptavidin binds biotin with 
an extremely high affinity (Kd - 10-l5 M) (Sano, et al., 1990). Protein A binds 
specifically to the Fc domain of most immunoglobulin G (IgG) types of molecules 
without disturbing their antigen-binding ability (Sjoholm, 1975). The gene of Sano's 
linker molecule was cloned into an expression vector (Uhlen et al., 1984; Sano et al., 
1995), and is efficiently expressed in E. coli (Studier and Moffatt, 1986). Ruzicka et al. 
(1 993) used avidin tetramer to link biotinylated antibodies to biotinylated DNA 
molecules. 
Avidin-biotinylated DNA complex can be prepared by mixing avidin and 
biotinylated DNA (Law et al., 1993). A primary antibody can be also linked to a DNA 
molecule through a biotinylated second antibody-streptavidin-biotinylated DNA complex 
(Zhou, 1993). Although avidin and streptavidin are commercially available, the 
following potential drawbacks reduce the attractiveness of these molecules as antibody- 
DNA linkers. Firstly, every primary antibody has to be biotinylated using a tedious 
procedure that decreases antibody-antigen affinity (Ruzicka et al., 1993). Secondly, the 
avidin-DNA conjugate lacks homogeneity (i.e., one avidin molecule may bind zero, one, 
two, three or four biotinylated DNA molecules), which reduces the reproducibility of the 
I-PCR system. Thirdly, binding avidin tetramer without marker DNA to antigen- 
biotinylated antibody complex will reduce the overall sensitivity of this system because 
no DNA tag will be present for amplification during PCR. Finally, binding four 
molecules of marker DNA to avidin tetramer (saturated) will prevent avidin from binding 
to biotinylated antibody, again reducing the number of DNA tags available for PCR. A 
primary antibody can also be linked to a marker DNA directly through cross linking 
technology that creates covalent bonds between the antibody and the DNA without using 
a linker molecule (Joerger et al., 1995). Although direct linking can be applied to any 
class or sub-class of immunoglobulin, it is not generally recommended due to the 
complexity of the manipulation involved (Sano et al., 1995). 
The advantages of using a protein A-streptavidin chimera as a bispecific linker 
molecule include: 1) the protein A moiety is a "universal linker" because it can bind 
specifically with high affinity to most immunoglobulin G from many species; 2) 
streptavidin moiety binds biotin with high affinity, and biotin can be easily incorporated 
into a marker DNA molecule; 3) because streptavidin can form a subunit tretramer, four 
protein A-streptavidin chimera molecules form an aggregate, which can bind four IgG 
and four biotin molecules independently by using an appropriate relative molar ratio of 
biotinylated DNA to protein A-streptavidin chimera (Niemeyer et al., 1999). One can link 
up to four DNA molecules to each bound antibody in situations when antigens are scarce, 
thus, amplifying the target signal (Sano et al., 1995). One potential problem associated 
with using protein A-streptavidin chimera as a linker molecule in a sandwich assay 
format is that the protein A portion of the chimera might bind to Fc portion of the 
antibody used to coat the surface of a microplate well (Ruzicka et al., 1993). However, 
this problem can be minimized by using F(ab')z or Fab fkagments, which lack Fc portion, 
as capturing antibodies (Sano et al., 1993). 
Marker DNA. Any DNA molecule (referred to as marker DNA thereafter) can be used 
in I-PCR assay, as long as this DNA sequence is not present in the sample to be analyzed. 
Case et al. (1997) used a fkagment of gene fkom a plant as the marker DNA. Maia et al. 
(1 995) produced a marker DNA fkom a virus gene. McElhinny and Warner (1 997) made 
their marker DNA out of a plasmid, while Kakizaki et al. (1 996) derived their marker 
DNA fkom a phagemid sequence. 
Two general methods are available for the preparation of biotinylated marker 
DNA. The first method uses DNA polymerase to incorporate a biotinylated 
deoxynucleotide into a DNA molecule with sticky ends. For example, McElhinny and 
Warner (1997) used Acc I and Hind I11 to digest pUCl9 plasmids to generate a 1.67 kb 
linear molecule. Then they used biotinylated deoxyadenine and the three other 
deoxynucleotides to produce a biotinylated pUC19 fragment under the action of Klenow 
large fiagment. Another method is the enzymatic amplification (PCR) of a template 
DNA with a set of primers, one of which contains one biotin per molecule. The resulting 
PCR product contains one biotin molecule at one of its termini (Kakizaki et al., 1996; 
Saito et al., 1999). 
Factors that affect the efficiency of marker DNA amplification include primer 
size, strand numbers, and the length of PCR products. Adequate size of primers increases 
PCR amplification efficiency. Joerger et al. (1 995) used two primer sets, PI 0 and P20 
(16 bp each) vs (G3 (20 bp) and G4 (22 bp) in their I-PCR assay. They found that the 
amplification potential of the G3 and G4 primer set (longer in length and higher thermal 
stability) was superior to that of the PI0 and P20 primer set. Joerger et al. (1995) also 
studied the effects of double stranded (ds) versus single stranded (ss) DNA as a template. 
The results indicated that 25 PCR cycles of ds DNA and 40 PCR cycles of ss DNA 
generated similar amounts of PCR products. The higher efficiency of double stranded 
DNA might be attributable to improved stability and increased number of templates with 
ds DNA compared to ss DNA. The lengths of PCR product also affect the efficiency of 
marker DNA amplification. In general, the molar yield was higher for shorter PCR 
products than for longer ones under identical PCR conditions (Joerger et al., 1995). 
Factors that affect the detection of PCR products include the lengths of PCR 
products and detection methods. The length of PCR products influences the amount of 
DNA-specific dye bound and therefore affects the band intensity on agrose or acrylamide 
gel. On the same molar base, the longer the PCR product is, the more intense the band on 
the gel will be. Hendrickson et al. (1995) generated three different lengths of PCR 
products in a single I-PCR reaction. They found that the band of the shorter PCR product 
(55 bp) generated from shorter marker DNA (55 bp) was less intense than that of the 
longer PCR products (85 and 99 bp) from the longer marker DNA (85 and 99 bp) on 
agarose gel stained by ethidium bromide. 
Methods of detecting PCR products also affect assay sensitivity. Niemeyer et al. 
(1997) compared three methods for detecting PCR products: 1) direct staining with a 
fluorescent intercalating dye, 2) an enzymatic assay utilizing doubly hapten-labeled 
products, and 3) gel electrophoresis. They concluded that the most sensitive method 
among the three was the fluorometric dye. 
In conclusion, I-PCR has been extensively used to detect a variety of membrane- 
bound and soluble antigens, and abundant evidence indicates that I-PCR is the most 
sensitive of currently available techniques to detect minute amounts of antigen. In 
addition, I-PCR technique is an exquisitely sensitive and non-invasive technique for 
detecting antigens on living cells. Therefore, we hypothesized that an I-PCR assay could 
be used to validate a model system for the detection of protein expression in single 
mammalian embryos and to work toward the goal of a non-invasive assay that could 
determine viability of a single mammalian embryo. 
Proteins Expressed by Preimplantation Embryos and Potential Candidates for 
Embryo Viabilitv Assay 
Many proteins are expressed by pre-implantation embryos. These proteins can be 
classified into two general categories, e.g., membrane-bound proteins and soluble 
proteins. Each category can be further divided into groups. The membrane-bound 
proteins that embryos produced include major histocompatibility complex (MHC) 
molecules, such as H - ~ D ~  and Qa-2 antigens in mice (McElhinny and Warner, 1997; 
McElhinny et al., 1998a, 1998b, 2000; Warner et al., 1993; Wu et al., 1999; Xu et al., 
1994); cell adhesion molecules, such as integrins in mice (Cai et al., 2000), N-cadherin in 
chickens (Garcia-Castro, 2000), connexins in mice (Lo and Gilula, 1979; McLachlin et 
al., 1983; Goodall and Johnson, 1984); and growth factor receptors (Lighten et al., 1997; 
Wiley et al., 1992). Soluble proteins produced by embryos include growth factors 
(Harvey and Kaye, 1990; Paria et al., 1991), cytokines (Orvieto and Bar-Hava, 1999; 
Orvieto and Schwartz, 1997), and prostaglandins (Niimura and Ishida, 1987). These 
membrane-bound and soluble proteins have diverse functions in embryo growth and 
development. However, the research reported herein was designed to concentrate on 
insulin receptor, epidermal growth factor receptor, and interleukin-6 based on the reasons 
discussed in the following sections. 
Expression and Functions of Insulin and Its Receptors 
Insulin is a small protein with a molecular weight of 5,700. It contains two 
polypeptide chains, A and B, joined by two disulfide bonds (Nelson and Cox, 2000). 
The first step in insulin action consists of binding of the hormone to specific cell surface 
receptors. The insulin receptor is a hormone-dependent protein tyrosine kinase that 
belongs to the family of tyrosine kinases associated with growth factor receptors and 
oncogene products. This receptor has two functional domains: an extracellular alpha- 
subunit containing theinajority or the totality of the hormone binding site and an 
intracellular beta-subunit possessing insulin-stimulated tyrosine kinase activity. This 
receptor's enzymatic function is essential for generation of the metabolic and growth- 
promoting effects of insulin. The activity of the insulin receptor kinase is regulated by the 
phosphorylation state of specific domains of the protein (Herrera and Rosen, 1987). 
Interaction of insulin with the receptor alpha-subunit triggers a conformational change, 
which is propagated to the beta-subunit and activates it. The active receptor kinase then 
leads to the phosphorylation of cellular protein substrates, which are likely to belong to 
two broad categories, those generating metabolic effects and those resulting in growth- 
promoting effects. The phosphorylated and active substrates then generate the final 
effects (Ballotti et al., 1989). 
Evidence suggests that insulin receptor (IR) or insulin like growth factor receptors 
(IGFR) are expressed on pre-implantation embryos. Insulin like growth factor I1 
transcripts were detected in mouse pre-implantation embryos (Lighten et al., 1997). 
Messenger RNA and protein for IGF-II, but not for insulin, were expressed in pre- 
implantation mouse embryos (Harvey and Kaye, 1992). Messenger RNAs of insulin 
receptor and IGF I and I1 receptors (IGF 1R and IGF2R) are present in rat embryos during 
the pre-implantation period (Lighten et al., 1997). Insulin-like growth factor I1 mRNA 
was present in embryos, oviducts, and uteri during the rat pre-implantation period (Zhang 
et al., 1994). In addition, transcripts for IR, IGF1 R, and IGF2R were present in human 
pre-implantation embryos (Lighten et al., 1997). Insulin receptor expression was seen in 
the ureteric bud branches and early nephron precursors in mouse metanephroi harvested 
at day 13 of gestation (Liu et al., 1997). Addition of insulin into the culture medium at 
low concentrations, ranging fiom 40 to 400 ng/mL, increased [3H] thymidine 
incorporation in mouse embryonic renal explants, and inclusion of IR beta-subunit- 
specific anti-sense oligodeoxynucleotide caused marked dysmorphogenesis and growth 
retardation of the metanephroi (Liu et al., 1997). Functional studies showed that 
incubating mouse embryos with physiological levels of insulin results in increased 
synthesis of RNA and DNA (Heyner et al., 1989). Indirect evidence also exists that 
insulin receptors are present on the ICM of mouse embryos (Harvey and Kaye, 1990) and 
proteins for IGF-I1 were expressed in pre-implantation mouse embryos (Harvey and 
Kaye, 1992). These findings suggest that insulin and related factors may play a role in 
early mammalian development (Heyner et al., 1989; Zhang et al., 1994). 
High resolution electron microscopy in conjunction with colloidal gold-labeled 
insulin has been used to provide direct evidence that insulin is internalized by pre- 
implantation mouse embryos by means of receptor-mediated endocytosis (Heyner et al., 
1989). In addition, immunocytochemical analyses at the blastocyst stage, using gold- 
labeled anti-insulin receptor immunoglobulin (IgG), have confirmed the expression of 
insulin receptors on all cells of the embryo, including the inner cell mass. This evidence 
also suggests that insulin receptor is expressed on pre-implantation mouse embryos, but 
its concentration is too low to be detected by conventional techniques (Lighten et al., 
1997). 
The functions of insulin and insulin like growth factor receptors were determined 
directly fiom culture studies. Insulin or IGF-1 at physiological concentrations stimulated 
pre-implantation mouse embryo growth (Harvey and Kaye, 1992). Insulin-like growth 
factor I1 (IGF-11) mediated growth in early mouse embryos (Harvey and Kaye, 1992). 
Exogenous IGF-I or IGF-I1 increased the cell number in cultured blastocysts, but a 
mutant form of IGF-I1 that strongly bound only the IGF-I1 receptor did not have an effect. 
Reduction of IGF-I1 expression by antisense IGF-I1 oligonucleotides decreased the rate of 
progression to the blastocyst stage and decreased the cell number in blastocysts. Pig 
blastocysts responded to physiological levels of insulin by increasing in diameter and in 
the rate of protein synthesis. Insulin at concentrations as low as 50 pM increased the 
number of mouse blastocysts and decreased the number of morulae by 10% after 54 h 
culture from 2-cell embryos. These results support the hypothesis that insulin has an 
important role in the regulation of growth during pre-implantation development (Harvey 
and Kaye, 1990), and support the hypothesis that insulin may act as a general embryonic 
growth factor. (Lewis et al., 1992). 
Expressions and Functions of Epidermal Growth Factor and Its Receptors 
Epidermal Growth Factor (EGF) is a small polypeptide (Fine et al., 1981) that 
exerts its functions by binding to specific receptors embedded in the cellular plasma 
membrane. After binding to its receptors, EGF moves to the cytoplasm in coated vesicles 
(CVs), and finally appears in lysosomes, where it is degraded and released from the cells 
(Fine et al., 1981). EGF has been isolated from rodent and human tissue, and probably 
exists in nearly all animal species. In humans, EGF has been detected in many body 
fluids (Carpenter, 1985). The expression of EGF in 22 to 30-day goat pregnancies was 
studied and the results indicated that EGF was expressed in the luminal and glandular 
endometrial epithelium on all days studied, but it was not detectable in trophoblastic cells 
or other embryonic structures (Flores et al., 1998). Epidermal growth factor, which is not 
synthesized by the mouse pre-implantation embryo, is present in both the oviduct and the 
uterus. Epidermal growth factor of maternal origin is present in both inner cell mass and 
trophectoderm cells in freshly isolated blastocysts but is present only in greatly reduced 
amounts following overnight culture of blastocysts in vitro (Dardik et al., 1 9W), 
indicating that blastocysts incorporate maternal EGF in vivo. 
Epidermal Growth Factor receptor (EGFr) in mice is a 170-kDa protein (Paria et 
al., 1991 ; Wiley et al., 1992) which is encoded by a single gene that produces two main 
transcripts that are translated and processed into a single polypeptide chain (Adamson, 
1990). In the mid 1980s, it was found that the EGFr has no subunit structure, and 
functions not only in ligand recognition, but also may produce an intracellular 'second 
messenger'. The receptor contains a protein kinase activity that is activated by the binding 
of EGF and this enzymatic function may, in turn, yield the critical 'second messenger', by 
phosphorylation of an intracellular protein (Carpenter, 1985). This intracellular protein is 
phosphorylated when exposed to both EGF and ATP. Epidermal growth factor induced 
approximately a two-fold increase in protein tyrosine kinase (PTK) activity in Day 4 
mouse blastocysts when they were incubated in the presence of a peptide substrate with a 
tyrosine moiety and ATP (Paria et al., 1991), indicating that EGF has a metabolic effect 
on pre-implantation embryos. 
Through antisense DNA inhibition and immunoprecipitation studies, it was shown 
that EGFr protein in mice was first synthesized at the blastocyst stage (Paria et al., 1991; 
Wiley et al., 1992). In humans, receptors for EGF are ubiquitous (Carpenter, 1985). It 
was observed that EGFr existed in the oocytes of primordial, primary, preantral, and 
antral follicles. Strong immuno-staining for EGFr was present in human thecal cells and 
EGFr was also expressed in some granulosa cells of primary to antral follicles (Qu et al., 
2000). Wiley et al. (1992) used immunoprecipitation and RT-PCR techniques to study 
the EGFr expression pattern of mouse embryos. They observed that unfertilized eggs and 
2-cell embryos had a very low reactivity to antimouse EGFr antibodies, but by the 4-cell 
stage and later the reactivity increased. Messenger RNA concentrations increased 
starting after 4-cell stage and EGFr protein was synthesized by 8-cell and older embryos. 
The widespread expression of EGFr throughout development fiom the beginning of 
gestation in mice suggests that it has important roles, which could include autocrine and 
paracrine stimulation (Wiley et al., 1992). Also in mice, EGFr is preferentially distributed 
on the basolateral surface of the trophectoderm and is present on the inner cell mass 
(Dardik et al., 1992). Evidence also exists that transforming growth factor-alpha (TGF- 
alpha) may act as a regulating factor for follicular development through binding to the 
EGF receptor (Qu et al., 2000). 
Epidermal Growth Factor acts as a mitogen for many cell types (Fine et al., 1981). 
Epidermal growth factor stimulated oocyte maturation by increasing prostaglandins (PG) 
in granulosa cells (Tsutsumi, 1993). Nuclear and cytoplasmic maturation of in vitro- 
grown mouse oocytes was also promoted by EGF treatment during meiotic maturation 
(De La Fuente, 1999). The presence of EGF during in vitro maturation, irrespective of 
concentration, stimulated bovine cumulus expansion and significantly increased the 
proportion of oocytes attaining metaphase 11, the rate of embryo cleavage, and the 
proportion of embryos reaching the 5 to 8 cell stage at 72 h post insemination. The 
presence of EGF also altered the pattern of protein neosynthesized during oocyte 
maturation in cattle (Lonergan, 1996). Evidence indicated that if placental EGFrs 
malfunction, the fetus is at a disadvantage, which may be attributable to poor placental 
growth and development, as well as a reduced ability of the placenta to perform a barrier 
function (Adarnson, 1990). Evidence also exists that the response on the binding of EGF 
to EGFr has a greater effect on the regulation of cellular differentiation than on cellular 
proliferation of two-cell mouse pre-implantation embryos cultured for 48 h (Brice et al., 
1993). 
Interleukin-6 (IL-6) 
Molecular Structure and Biolopical Functions. Interleukin-6 (IL-6) is 
a multifimctional glycoprotein of 185 amino acids that belongs to a class of hormone-like 
molecules termed cytokines. Interleukin 6 shares a structure of an antiparallel four 
a-helical bundle core with leukemia inhibitory factor (LIF), oncostatin M (OM), ciliary 
neurotrophic factor (CNTF), and IL-11 (Brakenhoff et al., 1995). IL-6 exerts its activity 
through binding to a high affinity receptor (Yamasaki et al., 1988). 
The IL-6 receptor (IL-6R) complex consists of two membrane proteins: an 80 kDa 
IL-6-binding receptor protein (Yamasaki et al., 1988) and a 130 kDa signal-transducing 
protein (gp 130; Hibi et al., 1990). The IL-6R complex consists of 468 amino acids, 
including a signal peptide of approximately 19 amino acids and a domain of 
approximately 90 amino acids that is similar to a domain in the immunoglobulin(Ig) 
superfamily ( Yamasaki et al., 1988). A cDNA encoding human gp130 has been cloned, 
which consists of 918 amino acids with a single transmembrane domain. The 
extracellular region comprises six units of a fibronectin type I11 module, and part of 
this region of approximately 200 amino acids has features typical of the cytokine receptor 
family. A cDNA-expressed gp130 showed no binding property to IL-6 or several other 
cytokines. Although a transfectant with an IL-6R cDNA expressed mainly low affinity 
IL-6 binding sites, an increase in high affinity binding sites was observed after 
cotransfection with a gp130 cDNA. This confirmed that a gp130 is involved in 
the formation of high affinity IL-6 binding sites. 
Production and Distribution. The production, secretion, and distribution of IL-6 in 
reproductive tissues have been extensively researched. Interleukin-6 activity was 
detectable in porcine uterine luminal fluid throughout the estrous cycle and pre- 
implantation period of pregnancy, and IL-6 mRNA was only detectable in day 11 
endometrium (Anegon et al., 1994). 
A research group in the United Kingdom used RT-PCR analysis to investigate 
expression of cytokine and receptor mRNA and found that IL-6R was expressed in a 
stage-specific manner throughout the preimplantation development of cryopreserved 
human embryos (Sharkey et al., 1995). Interleukin-6 was detectable in all seven-day old 
mouse embryos tested, which suggested that this cytokine may play an important role in 
early embryonic development (Kita et al., 1994). The results of an in vitro study revealed 
that IL-6 was differentially expressed at several stages of mouse preimplantation 
development and IL-6R was also detectable at these stages of development (Gerwin et 
al., 1995). 
A group of researchers in Switzerland used RT-PCR to investigate the expression 
of mRNA for IL-6 and IL-6R, and found that both mRNAs were expressed in normal rat 
brain in a region-specific manner and were developmentally regulated. The most 
pronounced expression of both genes was observed in the adult hippocampus. Lower 
levels were seen in the hypothalamus and the striatum. It was found that IL-6 rnRNA is 
predominantly located in neurons, indicating that IL-6 may have a specific role in 
neuronal functions such as differentiation or survival (Gadient and Otten, 1995). It was 
also found that IL-6 was produced in the whole placental tissue, isolated trophoblast 
(TC), and the villous core (VC) compartments of the placenta in vitro. Dot blot analysis 
and ELISA revealed that all three tissues linearly produced IL-6 over a 28-h culture 
period. It was found that IL-6 was detectable in all samples of coelomic and anmiotic 
fluids and in most extracts of placental and decidual tissues of normal human pregnancies 
between 7 and 12 weeks of gestation. The concentration of IL-6 varied among tissues 
and with gestational age, was significantly higher in decidual than in placental tissues, 
was significantly higher in coelomic fluid than in amniotic fluid, and was positively 
correlated with gestational age (Jauniaux et al., 1996). IL-6 mRNA levels decreased 
markedly during trophoblast differentiation in vitro. After 6 days in culture, when almost 
all the cytotrophoblast cells had fused and differentiated into syncytiotrophoblast cells, 
the amount of IL-6 mRNA was decreased by 60.9%. Interleukin-6 plays important roles 
in host defense, acute phase reactions, immune responses, and haematopoiesis. 
Exogenous IL-6 had differential effects on cytokine mRNA expression. When added to 
placental cultures during the first 6 days of culture, IL-6 markedly inhibited its own 
expression, and the expression of IL-1 alpha and IL-1 beta mRNA. However, when 
added to the cells during days 6 to 9 of culture, when most of the cells were 
syncytiotrophoblast cells, IL-6 stimulated IL-1 alpha and IL-1 beta mRNA expression 
(Stephanou et al., 1995). 
Evidence also exists that when continuously exposed to IL-6 (500 UImL) for up 
to 6 days, an enriched fiaction of human trophoblast cells (prepared by the isopycnic 
centrifugation of enzymatically dispersed term placenta) released significantly higher 
amounts of placental lactogen and placental lactogen mRNA in a dose-dependent fashion 
(Stephanou and Handwerger, 1994). A cloned gp130 could associate with a complex of 
IL-6 and soluble IL-6R and transduce the growth signal when expressed in a murine IL- 
3-dependent cell line (Hibi et al., 1990). 
Research Obiectives 
From the above discussion, we can see that insulin, epidermal growth factor, and 
interleukin 6 have many important functions in animal reproduction, especially in the 
regulation of preimplantation embryo growth and development. Any abnormality of 
these growth factors and their receptors could result in undesirable reproductive 
performance. Therefore, a simple, accurate, and speedy assay for these factors andlor 
their receptors may be of paramount importance to improving animal reproductive 
performance by accurate prediction of the viability of individual embryos. 
Many assay methods have been used to study insulin, epidermal growth factor, 
and interleukin 6, such as RT-PCR for detecting EGFr expression in human (Chia et al., 
1995) and bovine embryos (Watson et al., 1992), for detecting IL-6 expression on mouse 
embryos (Kita et al., 1994); commercial ELISA kits for measuring IL-6 secreted from 
human embryos (Seifer et al., 1993); immunocytochemical assays for studying the 
production of IL-6 by normal human trophoblast (Kameda et al., 1990). However, these 
techniques suffered either low sensitivity, were invasive in nature, or too were 
complicated to be commercially useful in single embryos. So, a quick and sensitive 
technique to detect these cell surface proteins needed to be developed. 
Irnrnuno-polymerase chain reaction, as mentioned above, is the most sensitive 
technique currently for the detection of either membrane-bound or soluble proteins. In 
addition, I-PCR is non-invasive and easy to perform. A number of molecules produced 
by preimplantation embryos are viability-related. These molecules, such as insulin 
receptor, epidermal growth factor receptor, and interleukin-6, could be used as an 
indicator of an embryo's health status. The purpose of this series of experiments was to 
determine the feasibility of using I-PCR to detect insulin receptor, and epidermal growth 
factor receptors on individual mouse embryo. In addition, recombinant IL-6 molecules 
instead of embryo-secreted IL-6 molecules were measured by I-PCR in this preliminary 
study because the former is free from other cellular protein contamination. Based on the 
recombinant IL-6 data, the I-PCR assay could subsequently be tuned to measure embryo- 
secreted IL-6 molecules. The data generated by these studies should be valuable for the 
future development of a single-embryo viability assay based on I-PCR. 
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Chapter 2 
THE PRODUCTION AND ASSAY OF 
PROTEIN A-STREPTAVIDIN CHIMERA FOR I-PCR 
Abstract 
Protein A-streptavidin chimera produced in E.coli is a component of I-PCR assay 
that was used to link antigen-antibody complex to biotinylated pUC19 fragment. In order 
to increase the production of this critical protein, a series of studies was conducted to 
determine factors that affected its yield. Isopropyl-P-D-thiogalactopyranoside induction 
time had a positive effect on the yield of chimeric protein. This protein increased from 
zero through four h of IPTG induction. After five h, the yield remained about the same 
or was reduced slightly. The effect of induction temperature was not clear-cut. 
However, it appeared that a slight increase in temperature from 37.0 OC to 37.5 "C 
increased protein A-streptavidin chimera production. The method of bacterial cell lysis 
also affected chimeric protein yields, with higher yields by sonication than by chemically 
induced lysis. Culture medium played a major role in the induction of chimeric protein. 
Terrific Broth was preferable to either M9 medium or Lennox L broth for inducing 
chimeric protein. Timing of centrifugation of bacterial lysate had a major effect on 
chimeric protein yields. Although centrifugation just before IgG-affinity chromatography 
did not seem to affect overall chimeric protein yields, centrifugation just before biotin- 
affinity chromatography column significantly reduced chimeric protein yield because 
substantial amounts of chimeric protein were discarded in the pellet. After purification, 
the physical and functional integrity of this protein was also analyzed. It appeared that 
this protein was highly purified and fully functional. 
Key words: chimeric protein, culture medium, protein purification. 
Introduction 
The bacteria transformed by pTSAPA-2 vector was produced by Sano et al. 
(1992). This vector contains a truncated protein A gene fused to a truncated streptavidin 
gene. Under induction by IPTG, a protein A-streptavidin chimera was produced. This 
chimeric protein binds many of the isotypes of IgG molecules at one end (protein A end) 
and binds to biotin at the other end (streptavidin end). This protein is one of the 
important components in I-PCR assay, because it provides a connection between 
antibody-antigen complexes and the biotinylated pUC19 fragment. 
Although the use of a protein A-streptavidin chimera was first described almost a 
decade ago by Sano et al. (1992), only one other research team has reported the use of 
this protein in an I-PCR assay (McElhinny and Warner, 1997). Very limited information 
was available fiom either of these groups concerning the factors affecting the chimeric 
protein yields. Increasing the chimeric protein yield is not only economically sound, but 
also simplifies subsequent testing of this protein. Preliminary data in our lab suggested 
that induction time and temperature appeared to affect the chimeric protein yield. So, 
controlled studies were conducted for critically testing the effects of these two factors on 
chimeric protein yield. The chemical lysis of bacterial cells in the original method 
described by Sano and Cantor (1990) was very tedious and time-consuming, so we chose 
to use a simpler sonication method (the improved method) instead. A simple comparison 
between these two methods was conducted to determine which method was superior in 
terms of chimeric protein yield. Culture medium plays an important role in both plasmid 
and protein production of bacteria. A very low yield of chimeric protein was produced by 
using M9 medium, which was suggested by Sano et al. (1992). So, two other culture 
media, TB and LB broth, were also explored for producing chimeric protein. According 
to the original protocol (Sano et al., 1992), after the crude extract of chimeric protein was 
obtained, it was first dialyzed in respective column buffer before going through an IgG 
column which bound to the protein A moiety and a biotin column which bound to the 
streptavidin moiety of the protein A-streptavidin chimera. It was observed that after 
passing through the first affinity column (IgG column), the chimeric protein was almost 
pure. However, a large proportion of protein was lost during the centrifugation step that 
occurred just before the biotin affinity column. In order to confirm the effect of 
centrifugation on the chimeric protein loss, a controlled experiment was also conducted 
to compare the effects of centrifugation versus non-centrifugation on the chimeric protein 
yields. 
In addition to the chimeric protein yield, the functional integrity of this protein is 
also important for conducting I-PCR assay. Two separate studies were conducted in this 
regard. The first study was imrnuno-blotting which was able to determine the molecular 
weight and identity of the chimeric protein. The second study was an ELISA assay which 
was able to determine whether the chimeric protein was bifunctional (could bind to both 
IgG and biotin). 
Materials and Methods 
Rea~ents and A D D ~ ~ ~ ~ u s  
The following ingredients were from Sigma Chemical Co. (St. Louis, MO): 
PMSF (Phenylmethanesulfonyl fluoride), deoxyribonuclease I and ribonuclease A, anti- 
streptavidin (rabbit, antisera), biotinamidocaproyl-alkaline phosphatase, LB Broth Base, 
and LB Agar Tablets, 2-iminobiotin agarose beads, and fish gelatin; the following 
ingredients were from Spectrum Laboratories, Inc. (Rancho Dominguez, CA): IPTG 
(Isopropyl-P-D-thiogalactopyranoside), SpectraRor* 7 dialysis membrane (MWCO: 
25,000) and ~~ectra/Por@ RC Irradiated DispoDialyzer (MWCO: 25,000); the following 
ingredients were from Bio-Rad Laboratories (Hercules, CA): ~mmuno-c lot^^ PVDF 
membrane, EIA Grade Reagent Gelatin, GAR-HRP (goat-anti-rabbit IgG-horseradish 
peroxidase conjugate), and Trans-Blot SD Semi-Dry Transfer Cell; IgG Sepharose 6 Fast 
Flow gel and PD-10 column were from Amersham Pharmacia Biotech Inc. (Piscataway, 
NJ); Aprotinin and Leupeptin were purchased from United States Biochemical Corp. 
(USB) (Cleveland, OH); Whatman No. 1 filter paper was from Fisher Scientific (Hanover 
Park, IL); Pepstatin A was from Roche Molecular Biochemicals (Indianapolis, IN); 
Branson Sonifier 450 (model 450) was from Branson Ultrasonics Corporation (Danbury, 
CT); Transformed E. Coli strain, BL21(DE3)(pLysS)(pTSAPA-2), was a gift from 
Dr. Takeshi Sano (Harvard Medical School, Cambridge, MA). 
Medium Preparation and Bacterial Culturing 
Preparation of LB Agar Plate. LB Agar Tablets (Sigma) were added to distilled water 
(one tablet150 ml) in a beaker on a stirring hot plate while stimng. After the tablets 
melted, the solution was autoclaved for 15 min at 121 OC. Ten ml of LB agar solution 
was added to 100-mm petri dishes (plates without antibiotics). After the liquid agar in 
the beaker had cooled, ampicillin was added to a concentration of 150 pg/mL. Ten mL 
of LB agarlampicillin solution was added to other 100-mm petri dishes (plates with 
ampicillin). After that, twenty-five pg/mL of chloramphenicol was added to the 
remaining melted agar and 10 mL of the agar was put into other petri dishes (plates with 
both ampicillin and chloramphenicol). The plates stayed at room temperature for four h. 
Then they were wrapped in parafilm and stored at 4 OC for up to 24 h before use. Before 
plating, the plates were inverted and incubated face down at 37 OC for 20 min to dry the 
plates. 
Preparation of LB and TB Broth. LB broth base powder (two d l 0 0  mL, 1% tryptone, 
0.5% yeast extract, and 0.5% NaC1) or TB broth powder (4.76 d l 0 0  mL plus 0.4 mL of 
glyceral, 1.2% tryptone, 2.4% yeast extract, 0.94% K2HP04, 0.22% KH2P04, and 0.4% 
glycerol) was dissolved in distilled water at room temperature without stirring. Once 
dissolved, the LB broth was autoclaved for 15 min at 121 OC and then cooled down to 
room temperature before use. 
Ori~inal Bacterial Culture. Ten mL of autoclaved LB broth were added into each of 
two 50-mL flasks. Then 150 pg/mL ampicillin and 25 pg/mL chloramphenicol were 
added to each flask. A stab culture of BL21(DE3)(pLysS)(pTSAPA-2) was put into each 
flask and cultured at 37 OC with shaking at 300 rpm for 11 h. One loopful of bacteria 
culture from one of the flasks was streaked on LB agar plate with selective agents. 
Plating Bacteria on LB Agar Plates. The original culture with LB broth was first 
diluted to achieve an absorbance of 1.000 at 600 nrn, then was further diluted 500 times 
in LB broth and 200 times in SOC medium. Ten p1 of final bacteria dilution was added 
to 90 p1 of SOC medium on agar plates with or without selective agents and spread with a 
sterilized spatula. Plates were incubated at 37 OC with maximium humidity for 24 h. 
M9-Supplemented Medium and Starter Culture. M9 medium was prepared by 
sequentially adding one mM MgS04,0.2% glucose, 1.5 pM thiamine, 0.5% casamino 
acids, two pg/mL d-biotin, 150 pg/mL ampicillin, and 25 pg/mL chloramphenicol to M9 
salt solution (42.3 pM Na2HP04,22 pM KH2P04,8.6 pM NaC1, 18.7 pM NH4C1, 
pH 7.4). Ten mL of sterilized M9 medium was poured into a 50 mL flask, and one 
isolated bacterial colony was added into the beaker and cultured for 15 h at 37 OC with 
shaking at 300 rpm. Four mL of the cultured cell suspension was added to 100 mL of M9 
medium and cultured under the same condition for an additional four hours. 
Preparing L a r ~ e  Batch Culture. Four mL of starter culture was added to 220 mL of 
M9 medium in each of 1000-ml flasks and incubated at 37 OC with vigorous shaking (300 
rpm) for about four h. When the kO0 reached 0.8 to 1 .O, either zero (control) or 0.5 mM 
IPTG (treatments) was added and cultures were continued to be incubated for 0,1,2,3, 
4,5, or 6 h with shaking. 
harvest in^ Bacteria. Fifty-mL of bacterial culture was centrifuged at 2300 x g at 4OC 
for 15 min. The supernatant was discarded. The centrifuge tube was reloaded and 
centrifuged under the same conditions. So each tube contained a bacterial pellet from 
100 ml original bacterial culture. After the supernatant was discarded, the centrifuge tube 
with bacterial pellet was fiozen at - 70 OC (for improved method), or 10 ml of wash buffer 
(100 mM NaCl, 10 mM tris-HC1, and 1mM EDTA of pH 8.0, at 4 OC) was added to the 
bacterial pellet (for original method). Cells were resuspended by vigorously shaking and 
were then re-centrifuged under the same conditions. The supernatant was discarded and 
ten mL of lysis buffer (2 mM EDTA, 30 mM Tris HCl,O.l% Triton X-100,O.S mM 
PMSF) was added. The bacteria were resuspended by shaking and vortexing. The 
bacterial suspensions were stored at -70 OC. 
Purification of Sano's Chimeric Protein 
Ori~inal Method. Ten mL of fiozen bacterial suspension in lysis buffer was thawed at 
room temperature for 45 min, at 4 OC for 1 h, and on ice for 4 h. After vortexing to 
homogenize the pellet, 86.05pg/mL PMSF, 0.4756 pg/mL leupeptin, and 0.6859 pg/mL 
pepstatin A were added and stirred occasionally for 20 min. When the lysate became 
very viscous, 10 pg/mL deoxyribonuclease I and 10 pg/mL ribonuclease A were added, 
and the lysate was incubated in a room-temperature water bath for 20 min with 
occasional mixing. After the lysate lost its viscosity, the tube was centrifuged at 
39,000 x G for 15 min at 4 OC. 
The pellet was dissolved in 3 mL of 7 M guanidine hydrochloride by vortexing at 
high speed. Then another 7 mL of guanidine hydrochloride was added followed by more 
vortexing and mixing. After the pellet was completely dissolved, the volume of the 
solution was increased to 100 mL by adding 7 M Guanidine hydrochloride and mixed 
thoroughly. The mixture was then put into a dialysis tube (Spectrum Laboratories, Inc.) 
and dialyzed against one liter of TST dialysis buffer (1 50 mM NaCI, 50 mM Tris-HC1, 
0.05% Tween 20,0.02% sodium azide, pH 7.5) supplemented with 86.05pg/mL PMSF, 
0.4756 pg/mL leupeptin, 0.6859 pg/mL pepstatin A in a one liter graduated cylinder 
overnight at 4 OC without stirring. The dialysis buffer was discarded and one liter of 
fiesh dialysis buffer was added and then dialyzed for 6 h with stirring. The dialysis was 
repeated for three additional times. 
IgG Sepharose 6 Fast Flow gel (Pharrnacia) packed in a Pharrnacia PD-10 
column was equilibrated sequentially with 1) three mL of 0.5 M acetic acid at pH 3.4,2) 
three mL of TST buffer (TST dialysis buffer without sodium azide), 3) three mL of 0.5 M 
acetic acid at pH 3.4, and 4) ten mL of TST buffer. The fluid was removed fiom dialysis 
tube and was centrifuged at 39,000 x G for 15 min at 4 OC. The supernatant was adjusted 
to a pH between 7.0 and 7.5. The supernatant was slowly applied to the IgG Sepharose 6 
Fast Flow column twice at 8 OC. After all the supernatant had passed through the column, 
the column was rinsed with 40 mL of TST buffer and the unbound proteins were washed 
off with 20 mL TST buffer. The column was washed with 2.5 mL of 5 mM ammonium 
acetate at pH 5.0. The bound protein was eluted with ten mL of 0.5 M acetic acid at 
pH 3.4 (eluting buffer I). Aliquots of 0.5 mL fiactions were collected. The binding and 
eluting procedures were repeated twice with the flowthrough to make sure all the 
chimeric protein in the dialysate was harvested. All fractions with absorbances at 280 nm 
higher than the eluting buffer I were pooled. The pooled fiactions were dialyzed in a 
spectra/Por@ RC Irradiated DispoDialyzer overnight with stirring at 4 OC in 500 mL of 
pH 11 -0 dialysis buffer (1 M NaCI, 50 mM sodium carbonate). The dialysate and 
washings of the DispoDialyzer were pooled and centrifuged at 39,000 x g for 15 min. 
The supernatant was applied to a biotin column (previously equilibrated with the pH 11.0 
dialysis buffer) at 8 OC. The column was rinsed with 40 mL of pH1 1 dialysis buffer and 
unbound proteins were washed off with 20 mL of pH 1 1 dialysis buffer. The bound 
proteins were eluted with ten mL of six M urea and 50 mM ammonium acetate buffer at 
pH 4.0 (eluting buffer 11). A volume of 0.5 mL fractions were collected. All fractions 
with absorbances at 280 nm higher than eluting buffer I1 were pooled. These binding and 
eluting procedures were repeated for three times with the flowthrough to make sure all 
the chimeric protein in the dialysate was harvested. Pooled fractions were dialyzed in a 
Spectra/Por@ RC Irradiated DispoDialyzer against 500 mL of Tris-buffered saline 
(150 mM NaCl, 20 mM Tris-C1, pH = 7.5) overnight with stirring. The volunle was 
recorded and protein concentration was measured spectrophotometrically at absorbance 
of A280. The chimeric protein was sterilized by passing through a 0.22 micron filter, 
aliquoted in 100 to 500 microliter volumes and stored at -70 OC. 
Improved Method. Ten mL of TST buffer supplemented with the protein inhibitors 
(2 pg/mL aprotinin, 2 pg/mL leupeptin, and 1 pg/mL pepstatin A) was put into each tube 
containing a frozen bacterial pellet and the bacteria were resuspended by hand-shaking. 
The contents of each tube (ten mL of the bacteria suspension) were transfered into a 
30 mL Pyrex beaker. The bacteria cells were lysed by sonifying for one min with a 
Branson Sonifier (Branson Ultrasonics Corporation) at Output Control #5 and Duty 
Cycle of 50%, and then stopped for three min. The sonifylng and stopping cycle was 
repeated three times. The lysate was centrifuged (first centrifugation) at 37,000 x g for 
20 min at 4 OC. The supernatant (supernatant of first centrifugation) was poured into a 
15-mL centrifuge tube, and two mL of six M urea in TST buffer was added to the pellet. 
A ten-pl pipet tip was used to break the pellet. After that the content was pipetted a few 
times every 10 min for one h with a three-mL plastic pipette to dissolve the pellet. The 
suspension (pellet of first centrifugation) was centrifuged (second centrifugation) at 
37,000 x g for 20 min at 4 OC. The supernatant (supernatant of second centrifugation, or 
crude extract of chimeric protein) was poured into a 15-mL centrifuge tube and frozen at 
- 20 OC until protein purification. A volume of 0.8 mL of 6 M urea in TST buffer was 
added to dissolve the pellet (pellet of second centrifugation). 
The crude extract of chimeric protein in the 15 mL centrifuge tube was mixed 
with eight mL of 6 M urea in TST dialysis buffer at room temperature. The solution was 
loaded into SpectralPor* 7 dialysis membrane (MCWC = 25,000) and dialyzed against 
100 mL of 6 M urea in TST dialysis buffer without protein inhibitor for 7 h at 6 - 8 OC 
with gentle stimng twice. The sample was again dialyzed against decreasing 
concentrations of urea in 100 mL TST dialysis buffer, 3 M urea with neither inhibitor nor 
stirring for 2 h and with stimng for 2 h, 1.5 M urea with proteinase inhibitors (2 pg/mL 
of aprotinin, 2 pg/mL of leupeptin and 1 pg/mL of pepstatin A) for 4 h with stirring, and 
0.75 M urea in TST dialysis buffer with proteinase inhibitors for 4 h with stirring. Finally 
the sample was dialyzed in 100 mL TST dialysis buffer without urea with proteinase 
inhibitors for 4 h with stirring and this last dialysis step was repeated twice. 
The dialysate and the washings of the dialysis tube were transferred into a 
centrifuge tube and centrifuged (or not centrifuged) at 37,000 x g for 15 min at 4 OC. The 
supernatant or the dialysate were diluted with TST buffer (with proteinase inhibitors) to a 
final volume of 20 mL. Then the content was mixed with a 3 mL plastic pipette for one h. 
The pH of supernatant was measured and adjusted to 7.0 to 7.5. The supernatant was 
slowly applied to an IgG Sepharose 6 Fast Flow column (prepared as described in the 
original method) twice at 8 OC. The column was rinsed with 40 mL of TST buffer, 
washed with 20 mL of TST buffer, and washed with 2.5 mL of 5 rnM ammonium acetate 
at pH 5.0. Bound protein was eluted with ten mL of eluting buffer I. 'A volume of - " 
0.5 mL fractions were collected. The flowthrough was loaded and eluted twice to ensure 
that all chimeric protein was harvested. All fractions with absorbances at 280 nm higher 
than eluting buffer I were pooled. The pooled fractions were dialyzed in a spectra@or@ 
RC Irradiated DispoDialyzer overnight with stimng at 4 OC in 500 mL of pH 1 1.0 
dialysis buffer. The dialysis tube was gently shaken for 30 min at room temperature to 
dissolve any precipitated protein. The dialysate and washings of the dialysis membrance 
were pooled and centrifuged (or not centrifuged) at 39,000 x g for 15 min. PH 11.0 buffer 
was added to the supernatant or dialysate to make a total volume of 20 mL and the 
diluted supernatant or dialysate were mixed with a three-mL plastic pipette for one h at 
room temperature. The 2-imino-biotin column was equilibrated with 40 mL of pH 1 1.0 
dialysis buffer. The chimeric protein solution was applied to the 2-iminobiotin agarose 
column three times at room temperature. The column was rinsed with 40 mL of pH 1 1 
dialysis buffer. Unbound proteins were washed off with 20 mL of pH 11.0 buffer. Bound 
proteins were eluted with ten mL of eluting buffer 11. A volume of 0.5 ml fractions were 
collected. All fractions with absorbances at 280 nm higher than eluting buffer I1 were 
pooled. The pooled fractions were dialyzed against 100 mL of 4.5 M urea in Tris- 
buffered saline for two h without stimng and two h with stimng, then dialyzed against 
100 mL of 3 M, of 1.5 M, and of 0.75 M urea in Tris-buffered saline for two h each with 
stirring. Finally the pooled fractions were dialyzed against 500 mL of Tris-buffered 
saline overnight with stirring. The volume of the dialysate was recorded and chimeric 
protein concentration was measured at A280. The dialysate was sterilized by passing 
through a 0.22 micron filter. Samples were stored in 50 pl volumes at -70 OC before use. 
Immunoblotting and Chimeric Protein Detection 
Separatin~ Proteins. Protein samples were mixed with sample buffer and heated at 
85 OC for six rnin. Ten microliter of the mixture was loaded in each well of a 3.0 % 
(upper) and 12.0 % (lower) discontinuous SDS-PAGE gel. The sample was 
electrophoresed at 5 mA for 30 min and then at 8 mA for another 90 min. 
Transfering Proteins from a SDS-PAGE Gel to PVDF Membrane. The construction 
of one TRANS-UNIT of Trans-Blot SD Semi-Dry Transfer Cell (BIO-RAD) as follows 
(from top to bottom). 
a. Graphite electrode (-) fixed to the plastic frame; 
b. Six layers of filter paper (Whatman No. 1, same size as the gel) wetted by slow 
immersion in cathode solution (0.04 M 6-amino-n-hexanoic acidJ0.025 M 
Tris/20% (vlv) methanol of pH 9.4); 
c. Three layers of filter paper (Whatman No. 1) wetted by slow immersion in 
Cathode solution; 
d. Polyacrylamide gel; 
e. PVDF membrane (pre-rinsed in distilled water, pore size 0.45 um) 
f. Three layers of filter paper (Whatman No. 1, same size as the gel slab) wetted by 
slow immersion in Anode #2 solution (0.025 M Tris/20% (vlv) methanol, 
pH 10.4). 
g. Six layers of filter paper (Whatrnan No. 1, same size as the gel slab) wetted by 
slow immersion in Anode #1 solution (0.3 M tris/20% (vlv) methanol, pH 10.4). 
h. Graphite electrode (+) fixed to the plastic fi-ame. 
Electrophoretic transfer was carried out at a constant current of 42 rnA (0.8 mAkrn2) for 
1 h at room temperature. 
Colorimetric Detection. The PVDF membrane with proteins transferred fi-om the SDS- 
PAGE gel was dried completely in the air by placing the membrane between filter papers 
for six days at 4 OC. The membrane was cut with a razor blade into 3 portions, I, I1 and 
111. The cuts were made just to the left of the standard lane at the left most of each 
portion. The membrane was wetted three times in PBST (138.6 mM NaCl, 2.716 mM 
KCl, 2.147 rnM KH2P04, 9.879 mM Na2HP04, and 0.1% tween 20) at pH 7.37 and was 
washed twice in ten mL of PBST, each for five min at room temperature. The membrane 
was then immersed at a 45' angle into ten mL of blocking solution (three % gelatin in 
PBS) and the solution was gently agitated on a rocking platform at room temperature for 
60 min. The blocking solution was decanted and the membrane was washed twice with 
ten mL PBST for five min each. Ten mL of primary antibody solution [rabbit anti- 
streptavidin, Sigma) was diluted to 1500, 1 :2,500, or 1 : 12,500 with antibody dilution 
buffer (1% gelatin in l x  PBST), then the diluted antibody solution was added to the 
membrane and incubated for two h with gentle agitation. The primary antibody solution 
was decanted. The membrane was washed twice, each for five min with gentle agitation, 
first with ten mL PBST and then with seven mL PBST. The PBST was decanted. Then 
ten mL of secondary antibody solution (GAR-HRP, BIO-IUD; 1 :6667 dilution in 
antibody dilution buffer) was added to the membrane and incubated with gentle agitation 
for two h. The secondary antibody solution was decanted. The membrane was washed 
with ten mL PBST twice, each for five min with gentle agitation. The PBST was poured 
off. Ten mL of substrate mixture [one mL of Opti-4CN (4-chloro-1-naphthol) diluent 
concentrate mixed with 9 mL of distilled water and 0.2 mL of Opti4CN substrate] was 
added to the membrane and incubated for 5 min without agitation. The substrate was 
poured off and the membrane was washed with 20 ml of distilled water for 15 min. 
Photographs of the membrane were taken using a digital camera with reflective light. 
The digital image was then manipulated with a densitometer. 
Immuno-Sandwich Assav for Linker Molecule 
In order to detect hnctional integrity of the chimeric protein obtained previously, 
an Immuno-sandwich assay was performed as follows. A 96-well plate (EIA plate) was 
coated (fiom top to bottom) overnight at 4 OC with 100 p1 per well of one of the 
following: IgG (100,50,25, 12.5, 6.25, 3.125, 1.563 and 0.781 pg in 0.2 M carbonate- 
bicarbonate buffer at pH 9.6, from columns 1 through 4; IgM (20, 10,5,2.5, 1.25,0.625, 
0.313,0.156 pg in 0.2 M carbonate-bicarbonate buffer at pH 9.6, fiom columns 5 through 
8; or 0.2 M carbonate-bicarbonate buffer at pH 9.6, from columns 9 through 12. The plate 
was washed three times with distilled water. The last distilled water wash was discarded 
and the wells were blotted dry. Non-specific sites were blocked by adding 200 p1 per well 
of 1% fish gelatin with 0.01% sodium azide in PBS. The well was covered with an 
adhesive plastic sheet to prevent evaporation and was incubated at 37 OC for 30 min. The 
blocking medium was discarded and the plate was washed twice with distilled water. 
Chimeric protein was diluted with 1% fish gelatin and 0.01% sodium azide in PBS to 
concentrations of 2.616 x 2.616 x 2.616 x lo-'', and 2.61 6 x lo-" M. Diluted 
chimeric protein (100 p1) was added into each well: 2.616 x 10-l3 M for column 1, 5, and 
9; 2.616 x lo-' ' M for columns 2,6, and 10; 2.616 x M for column 3,7, 11; and 
2.616 x lo-' M for column 4, 8, and 12. The plate was then incubated at room 
temperature for 45 min. After the incubation, the wells were washed twice with distilled 
water. Biotinamidocaproyl-alkaline phosphatase (Sigma) was diluted one thousand fold 
with 1% fish gelatin and 0.01% sodium azide in PBS and mixed on a tumbling mixer for 
about 3 min. One hundred p1 of diluted alkaline phosphatase was added to each well and 
incubated for 45 min at room temperature. The plate was washed five times with distilled 
water. Para-nitrophenol phosphate solution was prepared by mixing 22 mg of p- 
nitrophenol phosphate into 22 mL (one mglml) of Sorensen's glycine buffer (0.1 M, pH 
10.4) supplemented with 1 mM MgC12. Para-nitrophenol phosphate solution (200 p1) was 
added to each well. The absorbance was read at 405 nrn immediately and then every five 
min for two h. 
Statistical Analysis 
The data in Chapter 2 were analyzed either by Student's t-test or by Analysis of 
Variance. 
Results and Discussion 
Effects of Induction Conditions on Chimeric Protein Expression 
Many attempts were made to increase chimeric protein yield. The early results appeared 
to indicated that IPTG induction time and temperature had effects on chimeric protein 
yield. However, the data did vary somewhat in terms of optimal induction temperature 
and induction time. 
Length of Induction Time. The effect of induction time by IPTG on the yield of 
chimeric protein is shown in Figure 2.1. Chimeric protein yield increased from zero to 
five h (lane 1 through 6) of induction, with a sharp increase at five h. The protein yield 
subsequently decreased at six h of induction. 
t Chimeric protein 
Figure 2.1. The effects of induction time by IPTG on chimeric protein yields. IPTG 
(0.5 mM) was added to six out of seven bacterial cultures when the absorbance of 
bacterial culture at 600 nrn reached between 0.8 and 1. The flasks then cultured from 
zero (without IPTG) to 6 h. The chimeric protein crude extract was obtained as described 
in Materials and Methods (improved method). Eight microliters of crude extract and two 
microliters of sample buffer were loaded onto each well of the discontinuous SDS-PAGE 
gel. Lane M, protein marker; Lanes 1 through 7,0, 1,2,3,4, 5, and 6 h IPTG induction, 
respectively. 
The effect of IPTG induction time on chimeric protein yield was clearly visible. The 
longer induction time appeared to be beneficial for chimeric protein production, for 
example, both five and six h induction were better than zero to five h induction. 
However, we have no clear explanation for the sudden increase in chimeric protein 
production at five h (lane 6) of induction time. It seemed that factors other than the IPTG 
induction time might also have contributed to the sudden increase in the yield of the 
protein A-streptavidin chimera. The sudden decrease in chimeric protein yield at six h 
(lane 7) induction time might have resulted from the death of bacteria. 
Induction Temperature. The variations in chimeric protein induction in different flasks 
are shown in Figure 2.2. Bacteria grown in Flasks 3 and 4 (lane 9 and 10) appeared to 
produce more chimeric protein than in Flasks 1 and 2 (lane 7 and 8). Because the same 
culture medium and the same type of culture flask were used in this study, theoretically, 
the chimeric protein yield should have been the same among the 4 flasks. However, it 
certainly was not the case, because more chimeric protein was produced in flasks 3 and 4 
compared to flasks 1 and 2. The most likely reason for the variation among the flasks 
might be culture temperature. In the type of shaker used during incubations, hot air 
blows in from one side. Quite possibly, the temperature closer to the hot air vent might 
have been higher than the temperature further from the vent. The variations seen in this 
study led us to suspect that suboptimal temperature during incubation may have inhibited 
the protein A-streptavidin chimera expression. 
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Figure 2.2. Chimeric protein yields from different portions of bacteria cultures and 
different flasks. M9 medium was put into four 1000-ml flasks (220 mL each). After 
adding bacterial culture, the culture was incubated at 37 OC for about four h. The flasks 
were incubated for two h after IPTG induction. Crude chimeric protein extraction and gel 
electrophoresis were performed as described in Materials and Methods. Lane M, protein 
marker; Lanes 1 through 4, proteins in cell lysate of flask 1,2,3, and 4; Lane 5 and 6, 
protein in supernatant of flask 1 and 2; Lane 7 through 10, proteins in crude extract of 
flask 172,3,and4. 
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Figure 2.3. The effect of induction temperature on the yield of chimeric protein. Bacterial 
culture, chimeric protein induction, and crude chimeric protein extraction, and gel 
electrophoresis were done as described in Materials and Methods except that 4 different 
induction temperatures 37.5 OC (lanes 1 and 2), 38.0 OC (lanes 3 and 4), 38.5 OC (lanes 5 
and 6), and 39.0 OC (7 and 8) were used. 
The effect of the induction temperature on chimeric protein yield is shown in 
Figure 2.3. Three different temperatures were compared during induction with IPTG to 
determine whether incubation temperature influenced the yield of chimeric protein. More 
chimeric protein was produced if the induction temperature was adjusted to 38 OC (Lane 3 
and 4), but not to 37,37.5,38.5, or 39 OC. It seemed the induction temperature was very 
crucial for chimeric protein induction and the optimal temperature was confined within a 
very narrow temperature zone. 
In order to see clearly the effect of temperature and induction time on the 
chimeric protein yield, two factors (induction temperature and induction time) were 
combined in the following study. The effects of induction temperature and induction time 
on chimeric protein yield are shown in Figure 2.4. 
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Figure 2.4. The effects of induction temperature and induction time on chimeric protein 
yield. After addition of IPTG, three different temperatures (37,37.5, and 38.0 OC) and 6 
different induction times (0, 1,2,3,4, 5 h) were used to induce chimeric protein 
expression. Crude extract production and gel electrophoresis were performed as stated in 
Materials and Methods. Lanes 1 through 4,2  to 5 h induction at 37 OC; Lanes 5 through 
10,0 to 5 h induction at 37.5 OC; Lanes 11 through 14,2 to 4 h induction at 38.0.OC. 
As induction time increased, the yield of chimeric protein increased up to four h 
(Lanes 1 to 3 ,5  to 9, and 11 to 13), then decreased at five h (Lanes 4, 10, and 14). These 
findings were somewhat different from the timing of the previous study (Figure 2.2) 
where the optimal induction time seemed to be five hours rather than four hours. The 
reason(s) for this difference was not understood. Induction at 37.5 OC appeared to favor 
chimeric protein production compared to either 37 OC or 38 OC, but the differences 
seemed to be minor. This was somewhat different from what was found in the earlier 
study (Figure 2.3). In Figure 2.3, the optimal induction temperature seemed to be 38.0 OC 
rather than 37.5 OC. This difference in results might be due to the fact that the shaker 
used in this study was not the same as used in the previous studies, and its thermostat 
might have been slightly off scale. It is not difficult to see that a slight change in 
induction temperature would cause a measurable effect on chimeric protein induction. 
The Effect of Bacterial Lvsis and Centrifwation on Chimeric Protein Yields 
The relative amount of chimeric protein in different fractions during chimeric 
protein extraction from E. coli is displayed in Figure 2.5. The highest proportion of 
chimeric protein to total cellular protein was obtained in the supernatant of the second 
centrifugation step (Lane 4). 
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Figure 2.5. Relative amount of chimeric protein in different fractions during chimeric 
protein extraction from E. coli. Chimeric protein was extracted from bacteria as stated in 
Materials and Methods (improved method). Lane M, protein marker; Lane 1, proteins in 
lysate; Lane 2, proteins in supernatant of the first centrifugation; Lane 3, proteins in pellet 
of the first centrifugation; Lane 4, proteins in supernatant of the second centrifugation; 
Lane 5, proteins in pellet of the second centrifugation. 
The chimeric protein purification protocol was adjusted so that the cellular 
proteins were gradually eliminated. Because of this selective elimination, the proportion 
of the chimeric protein to the total proteins was gradually increased as the purification 
went on. This is exactly what is shown in Figure 2.5. A portion of chimeric protein in the 
supernatant of the second centrifugation (Lane 4) was higher than in the pellet of the first 
centrifugation (Lane 3), which was still higher than in the lysate (Lane 1). Unexpectedly, 
a portion of chimeric protein was lost late in the purification process, in the pellet of the 
second centrifugation. 
The effect of bacterial lysis method on the yield of chimeric protein is shown in 
Figure 2.6. The yield of chimeric protein was higher when the improved method was 
used (Lane 1 and 2) than when the original method was used (Lane 3 and 4) to extract 
the chimeric protein. 
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Figure 2.6. The effect of bacterial lysis methods on the yield of chimeric protein. Bacteria 
were either lysed by lysis buffer (original method) or by sonication (improved method). 
The crude extracts were obtained as stated in Materials and Methods. Lanes 1 and 2, 
bacteria lysed by improved method; Lanes 3 and 4, bacteria lysed by original method. 
The original method for lysing bacterial cells was tedious and time consuming. There 
might be several reasons for the differences in chimeric protein yield between these two 
methods. For example, it was very difficult to completely dissolve the pellet of the first 
centrifugation in the original method and this might have contributed to the loss of a 
portion of the chimeric protein. 
The effect of centrifugation on chimeric protein yield is shown in Figure 2.7. 
Centrifugation of the dialysate before the IgG affinity chromatography column did not 
reduce the yield of chimeric protein significantly. However, centrifugation before the 
biotin affinity chromatography column significantly reduced the yield of chimeric 
protein, indicating that the solubility of chimeric protein in the pre-biotin dialysis was 
sub-optimal. The highest yield of chimeric protein after IgG and biotin chromatography 
columns was obtained when centrifkgation steps prior to both chromatography columns 
were eliminated. 
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Figure 2.7. The effect of centrifugation on chimeric protein yield. The crude extract of 
chimeric protein from 900 mL of bacteria culture was pooled and randomly divided into 
9 portions. Three portions were assigned to each of three treatments. In Treatment 1, the 
dialysates before both IgG and biotincolumns were centrifkged. In Treatment 2, the 
dialysate before IgG affinity chromatography was not centrifkged, but it was centrifuged 
before biotin affinity chromatography. In Treatment 3, the dialysate was not centrifkged 
before either chromatography step. 
Without centrifugation priors to IgG and biotin chromatography columns 
(Treatment 3), the chimeric protein yield from 100 mL of bacteria culture was 6.392 mg 
after IgG chromatography and 3.21 7 mg after biotin chromatography. With 
centrifkgations prior to IgG and biotin chromatography columns (Treatment l), the 
chimeric protein yield from 100 mL of bacteria culture was 5.2 mg after IgG 
chromatography which did not differ from Treatment 3, and 0.1 1 mg after biotin 
chromatography which was significantly lower (p < 0.01) than from Treatment 3. The 
chimeric protein yield after biotin column in Treatment 2 was 0.921 mg and the yield was 
intermediate to Treatment 1 and 3. 
In the original protocol, dialysis of the crude extract of chimeric protein was 
followed by centrihgation in order to clarify the dialysate before applying it to the 
affinity columns. However, we found that protein loss was associated with 
centrifugation. As a result, less than one mg of protein A-streptavidin chimera was 
usually obtained fiom 100 mL bacterial culture. In order to confirm this finding, a 
controlled study was conducted with a direct comparison between centrihgation versus 
noncentrihgation before the affinity columns. The experimental results demonstrated 
that the centrihgation just before the imino-biotin affinity chromatography step was 
detrimental to the chimeric protein yield, and this centrihgation step was deleted from 
our purification protocol in later experiments. 
The Effect of Media on Bacterial Growth and Chimeric Protein Yields 
The effects of media on bacterial growth and chimeric protein yield are shown in 
Figure 2.8. In general, concentration (estimated by absorbance at 600 nrn) after culture in 
TB broth was higher than in either M9 or LB media. Bacterial growth in TB broth was 
significantly higher than in M9 medium starting at one h of culture (p < 0.0001), and 
remained significantly higher throughout the rest of the 7 h incubation period. The 
difference was not significant until five h of culture (p<0.0061) when the absorbance of 
TB culture was compared to that of LB culture. The absorbance was significantly higher 
in LB culture compared to M9 culture starting at two h of culture (p=O. 0076), and this 
trend continued throughout the rest of the culture period. At the end of the culture, the 
absorbance of TB culture was about twice as high as that of either M9 or LB culture. 
M9 medium [as recommended by Sano et al. (1992)l appeared to be inferior to 
TB broth for supporting bacterial growth to high density. Therefore, TB broth should be 
superior for M9 medium to maximizing chimeric protein production. To test this 
hypothesis, three different media were used in this study, namely M9 medium, LB broth, 
and TB broth. 
Figure 2.8. The effects of media on bacterial growth. Bacteria were cultured in three 
different media, TB broth, LB broth, and M9 medium for 8 h. The absorbances were 
measured hourly with a spectrophotometer at 600 nm. Each data point in the graph was 
represented by the mean of three readings. 
The reason to include LB broth was because it belongs to the category of rich medium 
(contains about half as much tryptone and yeast extract as TB broth and about twice the 
concentration of nutrients as M9 medium), and more importantly it contains no buffering 
system. By including this medium, the effect of buffering system on the chimeric protein 
induction might be separated from other factors. The results mentioned above supported 
the hypothesis that TB broth best supported high density of bacteria growth. 
The effect of media on chimeric protein yield is shown in Figure 2.9. The yields 
did not appear to be substantially different between LB and M9 cultures. However, 
bacteria cultured in TB broth produced about five to ten times more chimeric protein than 
bacteria cultured in LB broth or M9 medium. 
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Figure 2.9. The effect of media on chimeric protein yields. Bacteria were cultured in 
three media, M9 medium, LB broth, or TB broth. The crude extracts fiom the bacteria 
were obtained as stated in Materials and Methods. Lane M, protein marker; Lanes 1,2, 
and 3, crude extracts fiom M9 cultured bacteria; Lanes 4,5, and 6, crude extracts from 
LB cultured bacteria; Lanes 7,8,  and 9, crude extracts from TB cultured bacteria. 
This result was not exactly consistent with the effect of these media on bacterial 
growth shown in Figure 2.8. About twice as much chimeric protein should be produced in 
TB broth in comparison to either LB broth and M9 medium if the concentration of 
4 
bacteria in the media was the sole contributor to the chimeric protein yield. However, the 
yield was about 5 to 10 times more in TB culture than in either LB or M9 culture. The 
additional positive effect of TB broth on protein yield might be due to a positive effect of 
TB broth on plasmid amplification (personal communication; Sigma) at the time of P T G  
induction. Both the bacterial growth and chimeric protein production suggested that TB 
broth was the best of the three media for maximum chimeric protein production. 
The Functional Assav of Chimeric Protein 
The results of irnrnuno-blotting and chimeric protein detection are shown in 
Figure 2.10. More than 90% of proteins were transported from the SDS-PAGE gel to the 
PVDF membrane after blotting (Figure 2.10 a and b). As the primary antibody was 
diluted from 500 to 12,500 times, the band intensity was decreased substantially. 
However, even at the1 :12,500 dilution, the signal on the lane with the lowest amount of 
proteins (4.8 ng) from crude extract was still detectable. 
Both the yield and functional integrity of chimeric protein are important for I- 
PCR assay. The objective of the first study was to test whether the chimeric protein was 
intact by imrnuno-blotting. If the band detected corresponded to the known size of this 
protein (3 1 kd), we can assume that the chimeric protein was intact. The results 
demonstrated that the protein appeared to be intact, based on the presence of a single 
band at 3 1 kd (arrow). 
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Figure 2.10. The results of Immuno-blotting and chimeric protein detection. (a) Lane M, protein 
marker; Lanes 1 through 5,3000,600, 120,24, and 4.8 ng of chimeric protein per lane of agarose 
gel before blotting. (b) the same gel as in (a) after blotting. In (c), (d), and (e), the primary 
antibody was diluted 500,2,500, and 12,500 times, respectively. Lanes M, protein marker; Lanes 
l ,2 ,  and 3 contained 120,24, and 4.8 ng chimeric protein per lane, respectively. 
The results of ELISA assay for determining the functional integrity of chimeric protein 
are shown in Figure 2.1 1. For Negative Control and IgM coated wells, the absorbances at 41 0 nm 
did not change substantially over the course of I h incubation. However, the absorbances for the 
IgG coated wells increased during the entire incubation period and were observable even after 
only 10 minutes. The result demonstrated that the chmeric protein was fully functional, because 
the enzymatic reaction that resulted in increased absorbance was dependent on the binding of 
enzyme to the immobilized IgG molecules using both moieties of the bi-functional chimeric 
protein. The demonstration of functional integrity of chimeric protein used in our lab lays a firm 
foundation for the successful detection of target antigens by subsequent I-PCR assays. 
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Summary 
Chimeric protein is one of the important components used in I-PCR. A series of 
experiments was conducted to increase the yield of this protein through modifications to 
the original protocols. A number of factors were studied and several of them were 
demonstrated to play a role in increasing the production of the chimeric protein. By using 
the newly optimized protocol, the yield of chimeric protein was increased substantially. 
Experiments were also completed to test the fhction of this protein, and its physical and 
functional integrity was confirmed by these studies. 
The length of the bacterial culture period was shown to have a major influence on 
chimeric protein production by the transformed bacteria. Although some variation did 
exist in our data, the general trend was that the production of chimeric protein increased 
from zero to four h after IPTG induction [compared to two h after induction as suggested 
by Sano et al. (1992)l. Chimeric protein yield either remained the same or decreased 
slightly after four h IPTG induction. 
The effect of induction temperature tested on chimeric protein induction seemed 
to be ambiguous. In one study, 38.0 OC appeared to be optimal temperature and in the 
other, 37.5 OC appeared to be the best. This narrow shift in optimal temperature might be 
due to variation between the different shakers used in these two studies. The position of 
a flask in the shaker might also play a role due to differing proximities to the hot air vent. 
The method used to lyse bacterial cells also affected the chimeric protein yield. 
Lysing by sonication appeared to be superior in term of chimeric protein yield compared 
to chemically induced lysis. The increased yield with the sonication method might have 
resulted from the rapid and complete breakdown of the bacterial cells. Although 
chemically induced lysis immediately eliminated much of the other cellular proteins at an 
early step in the purification, much of the chimeric protein was also lost. In addition, the 
sonication method was simpler and shorter than the chemical lysis method. These 
advantages would be even more valuable when multiple samples are processed 
simultaneously. Culture medium played a major role in chimeric protein production. 
Terrific broth was the best medium among the three media used and supported high 
density bacterial cell growth. A five to ten-fold increase in chimeric protein yield was 
obtained with TB culture compared to either M9 or LB culture. With M9 medium, the 
optimal yield of pure chimeric protein was greater than 3 mg per 100 mL of bacterial 
culture when the improved method was used. LB broth did not seem to confer any 
advantage over M9 medium for chimeric protein induction, although LB broth contained 
twice the level of essential nutrients as M9 medium. This non-parallel result might be due 
to the lack of a buffering system in LB broth. Therefore, LB broth might not support a 
suitable pH range for bacterial growth at high density, which was confirnled by the 
similar rates of bacterial growth between M9 medium and LB broth. 
The centrifugation of dialysate just before irnmino-biotin affinity chromatography 
significantly decreased chimeric protein yield. After IgG affinty chromatography, the 
chimeric protein was almost pure. During the following dialysis, a visible precipitate 
formed. This was probably due to the high pH of the dialysis buffer (pH 1 I), which made 
the protein relatively insoluble. After centrifugation, most of the chimeric protein was 
lost in the pellet, leaving only a limited amount in the clarified dialysate. Chimeric 
protein loses were prevented by eliminating the centrifugation step, whlch certainly 
contributed to the high yield of chimeric protein using our improved method. 
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Chapter 3 
THE PRODUCTION AND ASSAY OF BIOTINYLATED PUC19 FRAGMENTS 
FOR I-PCR ASSAY 
Abstract 
pUC19 is a commonly used plasmid in molecular biology and its yield and quality 
are crucial for many analytical processes. Biotinylated pUC19 molecules were used as 
marker DNA to target antigens and these molecules were amplified by I-PCR assay to 
identifi the presence of target antigens. Commercially available bacteria were 
transformed by pUC 19 plasmid fiom a commercial source. The transformed bacteria 
were cultured under various conditions and pUC19 plasmid was purified and processed. 
Bacterial cells grew to significantly higher densities (p<0.01) when bacteria were 
cultured in TB broth [& 3.235k0.199 (1 5 h) and hO0 3 S96kO.394 (28 h)] compared to 
Lennox L broth (LB) cultures [(& 1.5 l6kO.04 (1 5 h) and & 1.676k0.055 (28 h)]. 
Similarly, significantly higher plasmid yields (p<0.01) were obtained in TB cultures 
[483.2+15.5 pg (15 h) and 439.4k14.9 pg (28 h) per 100 ml bacterial culture] compared 
to LB culture [15 and 28 h were 184.6k7.4 pg (15 h) and 207.1k9.3 pg (28 h). No 
difference (p > 0.05) was observed in bacterial cell density or plasmid yield between the 
two time periods within medium. In addition, the quality of pUC19 plasmid was 
independent of medium type and culture time. A novel procedure was developed for 
testing pUC 19 biotinylation efficiency, which was simpler, less expensive, and more 
efficient than existing procedures. For pUC 19 biotinylation, it appeared that incubation 
for 30 min at 37 OC led to higher biotinylation efficiency of the pUC19 fragment than for 
15 min either on ice or at room temperature. By using the optimized procedure, our 
biotinylated pUC19 fragments could be detected by I-PCR with as few as 58 PCR- 
generated or 6 Klenow fragment-generated biotinylated pUC19 molecules in 50 p1 of 
PCR reaction mix. We concluded that: (1) using TB broth, but not increasing the culture 
time, was beneficial for pUC19 yield; (2) pUC19 quality was not affected by the 
conditions under study; (3) our new method for testing the efficiency of pUC19 
biotinylation was very effective and could be used for testing the biotinylation of other 
molecules; and (4) our biotinylated pUCl9 fragments were fully functional. 
Key words: Culture medium, Plasmid, PCR, pUC19 
Introduction 
One of the important components in our I-PCR assay is a biotinylated pUC19 
fragment, which was linked by a recombinant chimeric protein to a target-specific 
antibody. The generation of biotinylated pUC19 fragments requires very pure and high 
quality pUC 19 plasmid. Although pUC 19 plasmid is commercially available, it becomes 
expensive to purchase in a large quantity. A large amount of pUC 19 was needed in our 
research due to the complicated testing procedures involved, thus it was necessary to 
produce pUC19 plasmid in a large quantity. Initially, we tried to use pUC1Ptransformed 
bacteria from another lab. However, our results were not very encouraging in terms of 
either pUC19 yield or quality. The reason(s) for our poor results were not completely 
understood since only very limited information was available on the factors that affect 
pUC 19 yield and quality. Although Tartof and Hobbs (1 987) found that using rich media 
(i.e., TB broth) resulted in increased yield of pUC18 plasmid DNA, no information was 
available on the quality of their plasmid produced. Frenkel and Bremer (1986) found that 
culture time affected the yields of pBR322 and pBR327 plasmids. However, pBR322 and 
pBR327 are low copy number plasmids, and it is not known whether this information is 
applicable to high copy number plasmids such as pUC 19. To solve the ambiguity, we 
transformed commercially available bacteria with commercial source pUC 19 plasmids. 
After transformation, the effects of culture media and culture time on the yield and 
quality of plasmid from E. coli were determined. In addition, a novel procedure was 
developed for testing the efficiency of pUC 19 biotinylation, which is less expensive and 
more efficient than the procedures presently available. 
Materials and Methods 
Reagents 
The following ingredients were from Sigma Chemical Co. (St. Louis, MO): 
streptavidin, rabbit anti-streptavidin (antisera), Lennox L broth, Terrific broth, LB agar 
tablets. The following ingredients were from New England BioLabs, Inc. (Beverly, MA): 
Pvu 11, ACC I, Hind 111, DNA polymerase I (Klenow large fragment), and pUC 19 plasmid. 
The following ingredients were from Gibco BRL (Grand Island, NY): isopropyl P-D- 
thiogalactopyranoside, 5-Bromo-4-chloro-3-indolyl P-D-galactopyranoside (X-Gal), 
biotin-14-dATP, deoxynucleotides, dNTP mix, and platinumB Taq DNA polymerase. 
The following ingredients were fiom Bio-Rad Laboratories (Hercules,CA): goat anti- 
rabbit IgG-horseradish proxidase conjugate (GAR-HRP), zeta-probeB Blotting 
membrane, and Immun- lot^ PVDF membrane. The EndoFree Plasmid Maxi Kit and 
QIAquick PCR Purification Kit were from Qiagen Inc. (Valencia, CA). ~ l o n a b l e s ~  Kit 
was from Novagen (Madison, WI). Whatman paper was from Fisher Scientific (Hanover 
Park, IL). The pUC 19 transformed bacteria was a gift fiom Dr. Carol Warner 
(Northeastern University, Boston, MA). 
Bacteria Transformation and Culture 
Transformation of Bacteria with Plasmids. The transformation reaction was carried 
out according to the manufacturer's instructions (Novagen) with a few modifications. 
Clonables Positive Control (5 p1 with insert to vector molar ratio of 2.5: 1) was put into a 
1.5-mL microcentrifuge tube and this was followed by adding 5 pl of 2X Ligation 
Premix. After thorough mixing, the tube was incubated at 22 OC for 15 min for the 
ligation reaction to take place and then the reaction product was stored on ice until 
transformation. Four tubes of NovaBlue singlesTM competent bacteria cells (Novagen) 
were thawed by immediately placing them on ice (all but the cap) for 3 min. The tubes 
were gently flicked 3 times, and 1 p1 of the positive control plasmid (Novagen), Test 
plasmid (0.2 ng) (Novagen), pUC19 plasmid dilution (2.5 pmoleImL, New England 
Biolabs, Inc.), and TE buffer (negative control) were added into tubes one to four. The 
tubes were immediately but gently flicked after each addition. After the addition of all 
reagents, the tubes were incubated on ice for 5 min, heated for exactly 30 seconds in a 
42 OC water bath, and placed on ice for 2 min. After this, 250 p1 of room temperature 
SOC medium was added to each tube and then tubes were stored on ice before use. 
Preparation of LB Agar Plates. LB Agar Tablets (Sigma) were put into 50 OC distilled 
water (one tablet/50 mL). The tablets were stirred on a stirring hot plate until completely 
dissolved. After autoclaving for 15 min and then cooling down to 45 OC, IPTG, X-gal, 
tetracycline, and ampicillin were added to final concentrations of 80 pM, 70 pg/mL, 
15 pg/mL, and 50 pg/mL, respectively. For plates without antibiotics, the antibiotics 
were excluded. After mixing the content and putting the beaker on a pipette tip box 
containing hot water (to prevent gel fiom forming inside of the beaker), ten mL of gel 
solution was introduced into each 100-mrn petri dish. The petri dishes were shaken to let 
the liquid gel uniformly cover the bottoms. The plates were stacked to prevent 
condensation and were cooled to room temperature. The plates were wrapped in parafilm, 
and were stored at 4 OC for up to one day before use. 
Plating and Culturing Transformed Bacteria on LB Agar Plates. These procedures 
were carried out according to manufacturer's instructions (Novagen) with a few 
modifications. Prior to transformation, the LB agar plates were placed (cover-side down) 
in a 37 OC incubator for about 20 min and removed just before plating. The 
transformation and negative control tubes were flicked 7 times, samples were removed 
fiom the middle of the transformation reaction and put on the LB agar plate (5 and 40 pl 
for Positive Control, 3 and 1.5 pl for Test plasmid, 0.2, and 0.04 p1 for pUC19 plasmid, 
which was put in 50 pl SOC on LB agar plates). After adding the bacterial suspension, a 
sterilized and cooled glass plating spreader was placed on the plate and the sample was 
evenly spread on the plate. Plates were incubated with cover-side down at 37 OC with 
maximum humidity for 24 h. Photograph of the plates were taken with transmitted light 
and the colonies were counted. 
Preparation of Starter #1 and #2. A volume of 4 mL of autoclaved LB broth was put 
into a 25-ml flask. Ampicillin and tetracycline were added at concentrations of 
120 pg/mL and 50 pg/mL, respectively. One blue colony was placed into the flask and 
cultured in a Controlled Environment Incubator Shaker (New Brunswick Scientific Co. 
Inc.) for 15 h with vigorous shaking at 250 rpm (Starter #I). The Starter #1 was diluted, 
plated, and cultured as stated below. To make Starter #2, a colony isolated from 
Starter #1 plate was cultured as stated above. 
Plating Bacterial Culture on A ~ a r  Plates. Bacteria culture was diluted with either LB 
or TB broth to an absorbance of 1 :000 at 600 nm. Two p1 of diluted sample was mixed 
with 998 p1 of LB broth. Then 5 p1 of this dilution was further diluted by mixing with 
995 p1 of SOC. Ten microliters of the end dilution plus 90 p1 of SOC were evenly spread 
over each plate. Plates were cultured at 37 OC with maximum humidity for 24 h. 
Preparation of Large Culture. A volume of 220 mL of either LB or TB broth was 
poured into each 1000-mL flask. Ampicillin and tetracycline were added to the flask to 
reach concentrations of 120 pg/mL and 50 pg/mL, respectively. After adding 0.22 mL 
Starter #2 to each flask, the flasks were cultured at 37 OC for 15 to 28 h with shaking at 
300 rpm. Bacterial growth (absorbance at 600 nm) was measured hourly in triplicates up 
to 15 h. Single readings were sequentially taken at 17,23, and 2 8 h of culture. 
Harvesting Bacteria. After cultured for 12, 17,23, and 28 h, the bacteria were harvested 
by loading 50 mL of bacteria culture into a 50-mL centrifbge tube. The bacterial cells 
were centrifuged at 6,000 x g for 15 min. The supernatant was discarded. The tube was 
reloaded once with additional 50 mL of bacterial culture and centrifbged under the same 
conditions. The resulting pellet (from 100 mL of bacterial culture) was frozen dry at 
-70 OC until use. 
pUC19 Plasmid Purification 
pUC 19 plasmid was purified using an EndoFree Plasmid Maxi Kit from Qiagen 
according to the manufacturer's instructions, with a few modifications. Briefly, one 
frozen bacterial pellet was suspendedin 10 mL of Resuspension Buffer (Buffer PI). 
Bacterial cells were lysed by adding 10 mL of Lysis Buffer (Buffer P2) and incubating 
for 5 min at room temperature after mixing. The reaction was stopped by adding 10 mL 
of Neutralization Buffer (Buffer P3) and mixing well. The lysate was poured into the 
QIAfilter Cartridge and incubated at room temperature for 10 min, then was filtered into 
a 50-mL centrifbge tube by gently pushing a plunger into the cartridge. After Buffer ER 
(2.5 ml) was added to the filtered lysate and mixed, the filtered lysate was incubated on 
ice for 30 min. The solution was then applied to the Buffer QBT- Equilibrated QIAGEN- 
tip and allowed to enter the resin by gravity flow. After washing the QIAGEN-tip with 
Buffer QC, pUC19 plasmid was eluted with 15 mL of Buffer QN. The eluted DNA was 
precipitated with isopropanol, washed with ethanol, and resuspended with endotoxin-free 
Buffer TE. The purified pUC19 plasmid was frozen and stored at - 20 OC until use. 
Biotinylated pUC19 Fra~ment Production and Assay 
Pvu I1 Digestion. pUC 19 plasmid was digested by Pvu I1 restriction enzyme (cuts at 
base number 306 and 628) according to the manufacturer's instructions (New England 
BioLabs, Inc.), with only a few modifications. Briefly, 5 pg of circular pUC19 plasmid 
were digested in a total volume of 50 p1 of 1X NEBuffer 2 supplemented with 10 units of 
Pvu 11 for 2 h at 37 OC. 
Ace1 and Hind 111 Digestion. pUC19 plasmid was digested by Acc I andlor Hind I11 
restriction enzymes according to the manufacturer's instructions (New England BioLabs, 
Inc.), with only a few modifications. Briefly, between 10 to 200 pg pUC19 plasmid was 
diluted in NeBuffer4 (1 00 pg/rnL final concentration) in microcentrihge tubes. Acc I 
(1 unitlpg pUC 19) and Hind III(4 unitslpg pUC19) were added. The tubes were 
incubated at 37 OC for up to 4 h. Because Acc I and Hind 111 cut pUC19 at base number 
429 and 447, respectively, a 2.67 kb fiagment with sticky ends was produced. 
The digested pUC19 was either run on an agarose gel directly to check digestion 
efficiency or was purified by QIAquick PCR Purification Kit for producing biotinylated 
pUC 19 fragments. 
pUC19 Fra~ment Purification. Biotinylated and non-biotinylated pUC 19 molecules 
were purified by QIAquick PCR Purification Kit (Qiagen Inc.) according to 
manufacturer's instructions. In brief, five volumes of Buffer PB were added to 1 volume 
of DNA solution. After mixing, the mixture was transferred into a QIAquick spin column 
and was centrihged at 10,000 x g for 1 min. To wash, 0.75 rnL of Buffer PE was added 
to the column and the column was centrifuged under the same conditions. To elute DNA, 
30 pl of Buffer EB was added to the column, incubated at room-temperature for 1 min 
and centrifuged at 10,000 x g for 1 min. The eluate was collected. 
Biotinvlation of pUC19. 
By Klenow Fragment. The pUC19 biotinylation was done according to 
the recommended protocol (New England BioLabs) with slight modifications. In brief, 
2.67 kb pUC 19 fragments (digested by Acc I and Hind 111) were diluted to a 
concentration of 33.33 pg/rnL in 1X DNA polymerase I buffer containing 1 unit DNA 
polymerase I (Klenow large fragment) per ug of DNA and 16.67 pM of each dNTP 
(biotinylated dATP, dCTP, dGTP, and dTTP) in volumes of 30 or 300 p1. After mixing in 
microcentrifbge tubes, the reaction mixtures were incubated for 15 min either on ice or at 
room temperature, or at 37 OC for 30 min. After the reaction was completed, pUC 19 
fragments were purified by QIAquick PCR Purification Kit. 
BY PCR. Non-biotinylated 2.6 kb pUC19 fragments were diluted with Buffer EB 
(10 mM Tris.HC1, pH 8.5) to a concentration of 2.0 x10-~ M. Thin-walled PCR tubes 
were each loaded with 48 p1 of master mix (see below) and 2 p1 of the prepared pUC19 
dilution. The primers were S1CTACTTACTCTAGCTTCCCGG3' (upper primer) and 
5'Biotin-CGCAGGAAAGAACATGTGAGC3' (lower primer). The upper primer binding 
site on pUC19 molecule starts (5' to 3') at 1901 bp and the lower primer starts at 795 bp. 
This generated a biotinylated pUC19 fragment that was 1107 bp in length. The PCR 
cycle was described below. After PCR reaction, biotinylated pUC19 fragments were 
purified by a QIAquick PCR Purification Kit. 
Assav of Biotinvlated pUC19 Fra~ments 
blot tin^ pUC19 DNA onto a Zeta-Probe Membrane. Biotinylated pUC19 fragments 
were subjected to electrophoresis through an agarose gel. The agarose gel was then 
shaken in 70 rnL 0.5 M NaOH and 1 M NaCl for 30 min at room temperature on a 
rotating platform. The solution was changed once and the gel was shaken for an 
additional 30 min at room temperature. A piece of sponge (5 mm thick and larger than 
the gel) was placed on the bottom of a buffer tray. A volume of 1500 ml of 10X SSC 
buffer (1.5 M NaCl and 0.15 M trisodium citrate at pH 7.0) was poured into the tray to 
immerse the sponge, and bubbles were squeezed out of the sponge. The SSC buffer was 
sucked out of the tray with a large syringe to a level that barely covered the sponge. 
Three sheets of prewetted (with 10 SSC) Whatman paper (a little larger than the sponge) 
were placed on the sponge. The surface of the paper was flooded with 10X SSC buffer, 
and the agarose gel was placed on top of the stack. A plastic wrap with a little window to 
allow only the gel and the Whatman paper through was rested on the sponge. A pre- 
wetted (with distilled water) Zeta-Probe membrane was placed on top of the Whatman 
paper. The surface of the Zeta-Probe membrane was flooded with 10X SSC. Two sheets 
of pre-wetted Whatman paper were placed on top of the Zeta-Probe membrane, and 
bubbles trapped between papers were removed. A 15-cm thick layer of paper towels was 
stacked on the Whatman paper. The DNA was transferred for 24 h at room-temperature. 
The level of 10X SSC was kept 4 cm deep during the entire transfer process. AAer 
transfer, the Zeta-membrane was separated fiom the gel and rinsed briefly in 50 ml of 2X 
SSC, then was blotted briefly with 3 layers of filter paper. 
DNA Alkaline Fixation. The Zeta-Probe membrane was placed (with DNA surface 
upper-most) on a pad of 3M paper saturated with 0.4 M NaOH for 10 min and rinsed in 
50 mL 2x SSC. The membrane was air-dried, then was stored between two pieces of 
filter paper in a plastic bag at room temperature until use. 
Colorimetric Detection of Biotinylated DNA. The dried membrane was wetted in 
50 mL PBST (phosphate buffered salinelo. 1% Tween-20), and then washed twice (5 min 
each) in 50 mL PBST in a plastic tray. The wetted membrane was put into 50 mL of 
room-temperature blocking solution (3% gelatin in PBS) and was agitated on a rocking 
platform for 60 min at room temperature. The blocking solution was discarded and 
replaced by 50 mL PBST. The membrane was washed in PBST twice, each for 5 min. 
After decanting the PBST, the membrane was incubated sequentially with 50 mL of 
streptavidin (1 pg/mL), 50 mL of primary antibody solution (rabbit anti-streptavidin, 
1500 dilution), and 50 mL of secondary antibody solution [goat anti-rabbit horseradish 
proxidase (GAR-HRP), 15000 dilution), each for 2 h with gentle agitation. Between the 
incubations, the membrane was washed twice with 50 ml of PBST, each for 5 min. After 
the final wash with PBST, the membrane was incubated with 51 ml of Opti-4CN diluent 
solution (substrate) for 2.5 min, then rinsed with 50 mL of distilled water for 15 min. 
Finally, the membrane was photographed. 
Polymerase Chain Reaction (PCR) 
The PCR reaction was performed in a thin-walled PCR tube containing a 48 p1 
mixture of template (2 p1 of pUC19 molecules) and master mix (48 pl). The 50 p1 of 
master mix contained 1 .S mM MgC1,0.2 rnM of each dNTP, 2 units of Platinum Taq 
DNA Polymerase, and 0.2 mM of each primer in 1X PCR buffer. The upper primer was 
~'CAGGCAACTATGGATGALICGA'~, and the lower primer was S'GGCGAAACCCG- 
ACAGGACTAT3'. The PCR reaction was carried out using the following settings: initial 
denaturation at 94 OC for 5 min followed by 35 cycles of denaturation at 94 OC for 1 min, 
annealing at 58 OC for 1 min, and extension at 72 OC for 1 min with a final extension at 
72°C for 5 min. With this set of primers, 769 base pair (bp) fragments from pUC 19 
templates were generated after PCR reaction. 
Gel Electrophoresis 
For gel electrophoresis, a horizontal mini-gel system (model MGU-202T, C.B.S. 
Scientific Company, Inc.) was used with an EC 105 electrophoresis power supply (E-C 
Apparatus Corporation). A 0.5% Agarose gel was made with molecular biology-certified 
agarose (Shelton Scientific, Inc.) in 1 X TBE buffer containing 0.1 1 pg/mL of ethidium 
bromide. The gel running buffer was also 1 X TBE with 0.11 pg/mL of ethidium bromide. 
After loading the wells (8 p1 of pUC19 sample and 2 p1 of gel loading solution for the 
small wells, or 12.8 p1 of pUC19 sample and 3.2 p1 of gel loading solution for the large 
wells), the gel was run for 1 h at a constant voltage of 95 V and then visualized and 
photographed under ultraviolet light to identify DNA bands. 
Statistical Analyses. 
The data in this section were analyzed either by Student's t-test or by Analysis of 
Variance. 
Results and Discussion 
The Yield and Oualitv of pUC19 Plasmid Purified from Bacteria Transformed at 
Northeastern University 
The yield of purified pUC19 plasmid from 100 mL of transformed bacteria 
culture is presented in Table 3.1. The average yield of purified pUC19 plasmid was 
76.5 pg/100 mL of culture, which was lower than what would be expected from a high 
copy number plasmid (300 to 500pg/100 mL culture; Qiagen, 1998). 
Table 3.1. The yield of purified pUC 19 plasmid from 100-mL culture of transformed 
bacteria. 
The quality of pUC 19 purified from the bacteria was shown in Figure 3.1. The 
purity of this plasmid was greater than 95% as shown on agarose gel. There were two 
bands (a lighter upper band and a heavier lower band) for every lane. The lighter band 
represented dimeric and the heavier band represented monomeric circular pUC 19 
plasmid. No genomic DNA contamination was detected. 
Figure 3.1. The quality of purified pUC 19 plasmid by EndoFree Plasmid Maxi Kit from 
the transformed bacteria. About 10 pg of pUC19 plasmid was loaded in each well of an 
agarose gel. DNA bands were visualized by ethidium bromide staining. 
Flask # 
Yield (pg) 
The minimum amount of biotinylated pUC 19 fragment detectable after PCR 
2 
77.19 
1 
65.45 
amplification was 2 p1 of 7.4 x 1 0-l2 M in 50 pl of PCR reaction (Figure 3.2). 
Mean ( ~ g )  76.48 
5 
82.45 
3 
78.09 
4 
79.2 
Figure 3.2. Efficiency of biotinylation of pUC 19 fragments. pUC 19 plasmid was purified 
from transformed bacteria (from Warner lab), then was digested with AccI and Hind111 
restriction enzymes. The linearized pUC 19 nlolecule was purified with QIAquick PCR 
Purification Kit (Qiagen) and biotinylated with biotinylated- 14-dATP through the action 
of Klenow large fragment of DNA polymerase I. The quality of biotinylated pUC 19 
hgment  was tested by PCR. Lane M, PCR marker; Lane 1, negative control; Lane 2 
through 7, two pl of 7.4 x 10 -* to 10 -I3 M biotinylated pUC 19 fragment (8.9 x 10lOto 
8.9 x lo5 molecules) as template. Eight pl of PCR reaction mixture and 2 p1 of gel 
loading solution were loaded in each well. 
The amplification power was too low to be useful in I-PCR assay because 
4 x 1 0'13 M of biotinylated pUC 19 is normally used (McElhinny and Warner, 1997). The 
reason (s) for such a low amplification power is unknown. It might be due to damage to 
the plasmid during purification process or due to intrinsic problem(s) associated with the 
plasmid, such as mutation of the primer-binding site. Due to the low amplification of this 
plasmid, we explored the possibility of transforming bacteria in our lab with 
commercially available pUC19 plasmid. 
The Yield and Oualitv of pUCl9 Plasmid Purified from Bacteria Transformed in 
Our Lab 
The Growth Status of Bacteria Under Culture. 
Newlv Transformed Bacteria. Two types of colonies were expected from these 
transformed bacteria. In the case of transformed bacteria with test and pUC19 plasmids, 
a blue colony was produced when the bacteria contained the respective plasmid and a 
white colony was produced when the bacteria did not contain the respective plasmid. In 
the case of transformed bacteria with positive control plasmid, a blue colony was 
produced when the bacteria contained the plasmid, but lacked the insert in the plasmid so 
the integrity of the gene was not interrupted. Alternatively, a white colony was produced 
when the bacteria either had the plasmid with the insert or did not have the plasmid. 
After the competent bacteria were transformed in our lab, they were cultured on LB agar 
plates. After 12 h incubation, the change of colony color was visible. After 24 h 
incubation, blue-white colonies were readily distinguished (Figure 3.3), and individual 
bacterial colonies were large enough for colony isolation. 
Figure 3.3. Blue and white colonies formed by bacteria transformed in our lab on LB agar 
plates. (a) Blue and white colonies formed by bacteria transformed by test plasmids 
(1.5 pl of transformed bacteria solution. (b) Blue colonies were formed by bacteria 
transformed by pUC19 plasmids (0.04 p1 of transformed bacterial solution). 
The numbers of colonies formed by the transformed bacteria on LB agar plates 
were shown in Table 3.2. The positive plasmid produced 93.1% white colonies which 
was very close to the 95% predicted value. When 0.04 p1 of pUC19 transformed bacteria 
solution was incubated on agar plate with antibiotics, the density of colonies on the plate 
was optimal for colony isolation. 
Table 3.2. Number of colonies formed on LB plates by transformed bacteria. 
Treatment 
Positive control 
Test plasmid 
pUC 19 plasmid 
Negative control 
(LB broth only) 
+I- antibodies Number of colonies 
(plating volume in 
microliters) Blue 
0 (too small to see color) 
0 (too small to see color) 
0 (too small to see color) 
Starter Cultures. After 12 h of culture, a portion of colonies on the plates turned 
blue in color. White and blue colonies could be distinguished very easily after 24 h of 
culture. Colony numbers of Starter culture 1 (SC 1) and Starter culture 2 (SC2) were 
shown in Table 3.3. There was no significant difference in colony numbers between 
antibiotic and non-antibiotic plates. This might be due to the fact that after first round 
selection, the bacteria without antibiotic resistance genes were drastically reduced. 
Table 3.3. Number of colonies formed by Starter Cultures 
at 24 h after culturing. 
I A B  1 3  12  1 98 13  1 
* Antibiotics 
Cultures 1 and 2. After 20 h of culture, the absorbance at 600 nm of 
culture 1 (Cl) was 1.948. After 19 h of culture, the absorbance at 600 nm of 
culture 2 (C2) was 1.875. After the plates were cultured for 24 h, white and blue colonies 
of both cultures could be seen very easily, and colonies were almost large enough for 
colony isolation. Colony numbers at 24 h of plate culture were shown in Table 3.4. 
Again, the number of colonies was similar between antibiotics and non-antibiotic plates. 
Table 3.4. Number of colonies formed by Cultures 1 and 2 at 24 h of culturing. 
Med 
Blue-White 
Large Culture. The relationship between the number of colonies formed on the 
LB agar plates and the absorbances at 600 nm was represented in Figure 3.4. The 
number of colonies formed on the plates increased in a linear fashion as the absorbances 
increased. By using the equation of y = 22.68~ + 4.18, the number of colonies (y) that 
will form on a plate under the same conditions can be predicted if the absorbance (x) is 
given. 
V I I I I I 
0 1 2 3 4 
Absorbance at 600 nm 
Figure 3.4. The relationship between the absorbance of a culture and the number of 
colonies formed on a plate. Transformed bacteria were cultured in TB broth with 
ampicillin and tetracycline as selective agents at 37 O C  and 300 rpm rotation for 12 h. 
The absorbances at 3.0,2.5,2.0, 1.5, and 1.0 at 600 nm were obtained by diluting the 
original culture with TB broth. Then every tube, except the last one (1.0 at 600 nm), was 
fixther diluted to achieve the absorbance of 1 .O. In this way, every tube has the same 
concentration of cells before plating. Each tube was then plated as stated in the Material 
and Methods. Each point was represented by the mean number of colonies fiom 3 plates. 
The absorbances of bacteria cultured on LB and TB broth is presented in Figure 
3.5. From 1 to 9 h, the absorbances of LB and TB cultures did not differ (p > 0.05). 
After 10 h of culture, the absorbances of TB cultures were significantly higher than LB 
cultures at the same time point. The highest absorbance for LB culture (1.916) was 
obtained at 17 h (not shown). The highest reading for TB (4.296) was obtained at 28 h 
(not shown). The logarithmic growth phase for both LB and TB culture was between 
11 h to 13 h of culture. At the end of culture, the absorbance of TB broth was more than 
double that of LB broth. This may be because TB broth is richer than 
LB broth (Sambrook et al., 1989), so TB broth could support higher density of bacterial 
-0- TB Broth 
-A- LB Broth 
0  1  2  3  4  5  6  7 8 9 l O l l l 2 l 3 l 4 l S I 6  
Culture time (h) 
Figure 3.5. The absorbances of bacteria cultured in either TB or LB broth. 
Samples were taken hourly from zero to 15 h and absorbances were measured 
with a spectrophotomer at 600 nrn. The average absorbance from three flasks of 
either TB culture (0) or LB culture (A ) was calculated and the mean (with standard error) 
was plotted against time in h. 
* Absorbances of TB and LB cultures starting from 10 h to the end of culture (15 h) 
differ significantly ( p  4 .01) .  
Figure 3 .6  represents the mean number of colonies formed on LB agar plates by 
bacteria cultured in TB or LB broth for different periods of time. Overall, as culture 
time increased, the number of colonies formed on the plates decreased. The colonies 
fiom TB culture decreased at a faster rate over time when compared to LB culture. The 
most likely reason for the sharp reduction in colony number was that the survival rate of 
bacteria were decreased as the culture time extended. 
30 
25 
20 Colonies .TB 15 LB 
10 
5 
0 
12 17 23 28 
Time (h) 
Figure 3.6. The mean number of colonies formed on LB agar plates by bacteria cultured 
in TB and LB broth for different periods of time. Samples were taken at 12, 17,23, and 
28 h of cultures. The sample was diluted and plated on LB agar plates. The plates were 
cultured at 37 OC for 24 h. The numbers of colonies were counted. The mean colony 
number from three plates was presented at each time point. 
The Yield and Quality of pUC19 Plasmid. Table 3.5 shows the yields of purified 
pUC 19 plasmid from 100 mL cultures of bacteria grown either in LB or TB medium and 
for either 15 or 28 h. There was no difference (p > 0.05) in the mean yield between the 
two culture periods within the same medium. However, a significantly higher yield was 
produced in bacteria cultured in TB broth than in LB broth. The mean yield of pUC19 
plasmid from 100-ml TB culture was 483.2 pg and 439.4 pg for 15 h and 28 h of culture, 
respectively, which was within the predicted range of 300 to 500 pg per 100 ml of culture 
(Qiagen, 1998), but was about half of what was obtained using another high copy number 
plasmid, pUC18 (Tartof and Hobbs, 1987). The reason for the difference in yield is not 
clear because pUC 18 and pUC 19 are high copy number plasmids and should not differ in 
plasmid yield. However, Tartof and Hobbs (1987) used the alkaline lysis procedure to 
extract DNA. This might have contributed to the increased DNA yield in their study. 
Table 3.5. The pUC19 yields purified from bacteria grown in either LB or TB broth and 
for either 15 or 28 h. 
Media I LB 
Culture c
time (h) 
Yield 170.0 
Table 3.6 compares the yield of pUC19 plasmid purified fiom bacteria 
transformed either in our lab or in Warner lab. The yield of pUC19 plasmid purified 
fiom the bacteria transformed in our lab was significantly higher (p0.05) than the yield 
fiom bacteria transformed in Warner's lab. We do not know exactly why the yield of 
pUC19 plasmid from bacteria fiom Warner's lab was lower, but speculate that mutations 
might have occurred to the origin of replication on pUC19 plasmid and this might have 
reduced its replication efficiency. 
Table 3.6. The yield (ug per 100 ml) of pUC19 plasmid purified fiom 
bacteria transformed either in our lab or in Warner lab and grown in LB 
broth. 
The quality of purified pUC19 plasmid is shown in Figure 3.7. Only one band is 
shown in most of the lanes. A few lanes have one or two faint bands 
above the major band. The fainter bands on the top of lane 9,12, and 13 appeared to be 
genomic DNA contamination based on this gel. 
Figure 3.7. The quality of purified pUC19 plasmid shown in agarose gel. Bacteria 
transformed with pUC19 plasmid in our laboratory were cultured in either LB or TB for 
either 15 h or 28 h. One microgram of purified pUC19 plasmid fiom each 100-ml culture 
was loaded per lane. Lane M, 1 kb ladder; Lane 1, Pvu 11-digested pUC 19; Lanes 2 
through 4, bacteria cultured in LB broth for 15 hours; Lanes 5 through 7, bacteria 
cultured in LB broth for 28 h; ~ a n ~ s  8 through 10, bacteria cultured in TB broth for 15 h; 
Lanes 11 through 13, bacteria cultured in TB broth for 28 h. 
Figure 3.8 shows the Pvu 11-digested pUC19 fragment on an agarose gel. The 
DNA was 100% digestable and a single band was shown in every lane loaded with 
digested DNA. The results appear to disprove the possibility of genomic DNA 
contamination. Consequently, the accessary bands likely represented the multimeric 
forms of pUC 19 plasmid (Qiagen, 1998). 
Figure 3.8. Non-digested and Pvu II-digested pUC19 plasmid on agarose gel. pUC19 
plasmid fiom the same sources as Lanes 3,6,9, and 12 in Figure 3.7 were digested with 
Pvu 11. This produced two fragments. The large fragment was 2363 bp and the small 
fragment was 323 bp. One microgram of digested pUC19 plasmid was loaded in each 
lane. Lanes 1 and 13,123 bp ladder; Lanes 2 and 12,l  kb ladder; Lanes 3,5,7, and 9, 
non-digested pUC19 from the same sources as in lanes 3,6,9, and 12 in Figure 3.7. 
Lanes 4,6,8, and 10, one microgram of Pvu II-digested pUC19 from lanes 3,6,9, and 12 
in Figure 3.7. 
Figure 3.9 shows the amplification efficiency of Pvu II-digested pUC 19 plasmid 
purified from bacteria incubated for different times and in different media. Incubation 
time and media had no effect on the amplification efficiency of linear pUC 19 molecule 
by PCR. The significance of this information is that using TB broth is superior to LB 
broth because the yield was significantly increased on one hand, and the quality of 
pUC 19 was not lowered on the other hand. 
Figure 3.9. PCR anlplification efficiency of pUC19 molecules from bacteria incubated in 
different media and for different time periods. Purified pUC 19 plasmid was digested by 
Pvu I1 and the digested molecules were purified. Two microliter of digested pUC19 at 
2 x 10-l3 (heavy band) and at 2 x 10-l4 M (light band) were amplified by PCR and eight 
microliter of PCR reaction was loaded in each lane of an agarose gel. Lanes 1 and 2, Pvu 
11-digested pUC19 fiom the same source as in lane 3 of Figure 4.7; Lane 3 and 4, Pvu II- 
digested pUC19 fi-om the same source as in lane 6 of Figure 4.7; Lane 5 and 6, Pvu II- 
digested pUC19 fi-om the same source as in lane 9 of Figure 4.7; Lane 7 and 8, Pvu II- 
digested pUC19 fi-om the same source as in lane 12 of Figure 4.7. 
PUC19 Plasmid Biotinylation and Detection of pUC19 Biotinylation Efficiencv. 
Figure 3.10 shows the time required for the complete digestion of one ug of 
pUC19 plasmid with one unit ofAcc I. One hundred and sixty min were needed for 
100% digestion (lane 9) under the conditions used. 
Figure 3.1 1 shows the time required for the complete digestion of pUC19 plasmid 
by Hind I11 (4 unitslmg of pUC19). One hundred and forty (Lane 8) min were needed for 
100% digestion under the conditions used. 
Figure 3.10. The time course of pUC19 digestion by Acc I. The purified pUC19 plasmid 
was digested with 1 unit of AccI per microgram of pUC19 plasmid. The digestion lasted 
up to 220 min and samples were taken every 20 min. One microgram of pUC19 DNA 
was loaded in each lane of an agroase gel. Lane M, 1 kb ladder; Lane 1, undigested 
pUC19; Lane 2 through 12,20 to 220-minute Acc I-digested pUC19. 
Figure 3.1 1. The time course of pUC 19 digestion by Hind 111. The purified pUCl9 
plasmid was digested with 4 units of Hind 111 per microgram of pUC19 plasmid. The 
digestion lasted up to 220 min and a sample was taken every 20 min. One microgram of 
pUC19 DNA was loaded in each lane of an agroase gel. Lane M, 1 kb ladder; Lane 1, 
undigested pUC 19; Lane 2 through 12,20 to 220-min Hind III digested pUC19. 
Knowledge of the minimum time necessary for complete digestion of the pUC19 
plasmid is very important because incomplete restriction digestion would lead either to 
low biotinylation rate or to a pUC19 fragment with both ends biotinylated. In either case, 
the sensitivity of I-PCR would be reduced. In addition, incubation after complete 
restriction digestion of pUC 19 may lead to nonspecific plasmid breakdown, which would 
also have a negative effect on the efficiency of I-PCR. With this information in mind, we 
used double enzyme digestions of pUC 19 plasmid for 4 h because the two enzymes in the 
same system might influence each other and reduce the digestion efficiency. The 
advantage of using double digestion is that the incubation time was reduced compared to 
two single digestions. This minimized non-specific destruction of plasmid DNA. 
Figure 3.12 is the schematic representation of a system for detecting pUC 19 
biotinylation. 
Figure 3.12. Schematic representation of pUC 19 biotinylation detection system. 
Biotinylated pUC 19 molecules (A) were fixed onto the Zeta-probe membrane. 
Streptavidin (B) was introduced to interact with the biotin group (arrow) on the DNA. 
Rabbit anti-streptavidin antibody (lSt Ab, IgG) (C) was then added to bind to streptavidin. 
This was followed by goat-anti rabbit IgG (2nd Ab) (D) conjugated to horseradish 
peroxidase (pointed box), which interacted with lSt Ab. Opti-4 CN (4-chloro- 1-naphthol) 
(E) was added and purple precipitate (F) was generated under the action of horseradish 
peroxidase. Biotinylation efficiency was directly related to the intensity of the purple 
precipitate. 
Figure 3.13. A new method for testing biotinylation efficiency of pUC 19 fragments. 
PUC19 plasmid was digested by Acc I and Hind 111. The linear DNA molecules were 
purified by QIAquick PCR Purification Kit. The pUC 19 biotinylation was achieved 
either by Klenow large fragment with biotin-dATP or by PCR reaction with biotinylated 
primer using linear pUC 19 molecules as templates. One microgram of pUC 19 was loaded 
in each well of an agarose gel. After electrophoresis, the linear DNA molecules were 
transferred from the agarose gel onto a Zeta-probe membrane and were detected with 
Opti-4 CN system. (a). Biotinylated pUC19 bands on an agarose gel detected by ethidium 
bromide staining. Lane M, 1 kb ladder, Lane 1, non-biotinylated linear pUC 19 molecule; 
Lanes 2,3, and 4, Klenow large fragment-generated biotinylated pUC 19 fragment under 
the conditions of 15 min on ice, 15 min at room temperature, and 30 min at 37 OC, 
respectively; Lane 5, PCR-generated biotinylated pUC 19 fragment. (b) pUC 19 molecules 
transferred onto Zeta-probe membrane; (c) agarose gel after transferring; and (d) 
biotinylated pUC 19 on the Zeta-probe membrane as detected by the Opti-4 CN system. 
Figure 3.13 shows a novel and quantitative method for detecting pUC 19 
biotinylation efficiency. The biotinylation efficiency of PCR-generated pUC 19 fragment 
with biotinylated primer did not differ from that of Klenow large fragment-generated 
biotinylated pUC 19 fragment. When pUC 19 fragments were biotinylated by incubation 
with Klenow Fragment at 37 OC for 30 min, more pUC19 fragments were biotinylated 
compared with 15 min incubation either on ice or at room temperature. 
Up to now, it has been very difficult, if not impossible, to do side by side 
comparisons of DNA biotinylation efficiency. The most widely used method for 
detecting DNA biotinylation is streptavidin-agarose affinity chromatography. This 
involves a tedious handling procedure, including boiling for a long time period to 
dissociate the binding between biotin and streptavidin. In addition, a relatively large 
quantity of biotinylated DNA is required to perform affinity chromatography. 
Furthermore, it is very expensive to compare multiple samples. However, using our 
detection system with all the commercially available ingredients, one microgram of 
biotinylated pUC 19 per sample was sufficient for making side by side comparisons of 
biotinylation efficiency. This system proved to be effective, efficient, and ecomonical. 
Figure 3.14 shows PCR amplification efficiency of biotinylated pUC 19 fragments. 
For PCR-generated biotinylated pUC 19 fragments, at least 50 molecules in 50 p1 were 
required for detecion after PCR amplification (Lane 6). For Klenow fragment-generated 
biotinylated pUC19 fragments, as few as 5 molecules in 50 p1 were readily detectable 
after PCR amplification (Lane 7). 
The above results demonstrate that the biotinylated pUC 19 fragments generated in 
our lab were very high in quality, because: 1) no DNA contamination was observed, 
2) biotinylation efficiency was very high, and 3) signals were generated by PCR 
amplification even with a small number of pUC19 molecules. 
Figure 3.14. The amplification efficiency of biotinylated pUC 19 fragments. Various 
amounts of biotinylated pUC 19 fragments (both PCR-generated and Klenow large 
fragment-generated) were added to 50 p1 of PCR master mix in thin-wall PCR tubes. 
After PCR reaction, 8 p1 of PCR reaction and 2 p1 of gel loading solution were loaded in 
each well of agarose gel containing ethidium bromide. Bands on agarose gels were 
visualized under W-light. In (a), Lane M, PCR ladder; Lanes 1 through 8,4.8 x lo6, 
4.8 x lo5, 4.8 x lo4, 4.8 x lo3, 4.8 x lo2, 4.8 x lo', 4.8 x lo0, and Omolecules ofPCR- 
generated pUC19 fiagments used as templates. In (b). The same molar concentrations of 
pUC19 as in Figure 3.14 (a) were used as templates, but Klenow large fiagment- 
generated biotinylated pUC 19 molecules were used as templates. 
Summary 
High quality biotinylated pUC19 was prepared as one of the components of our 
1-PCR assay. Commercially acquired bacteria were transformed with commercially- 
acquired pUC19 plasmids. The transformed bacteria were cultured under various 
conditions to increase the production of this plasmid. After harvesting the bacteria, the 
plasmids were purified with Qiagen EndoFree Plasmid Maxi Kit, then were cut by Acc I 
and Hind I11 restriction enzymes. Biotinylated pUC 19 fragments were produced either 
with biotin-dATP through the enzymatic action of DNA polymerase I (Klenow large 
fragment) or by PCR amplification of a pUC19 fragment using a biotinylated primer. 
The effect of a number of factors were studied in order to increase the yield and 
quality of biotinylated pUC19 fragments. Several of them were correlated with either 
yield or quality, while other factors appeared to be ineffective. First of all, culture 
medium played a key role in increasing plasmid yield. Yield of pUC19 plasmid was 
almost doubled when TB broth rather than LB broth was used to culture transformed 
bacteria. The contribution of TB broth was reflected by increased cell density at the end 
of culture, since the absorbance of TB culture averaged twice that of LB culture. Culture 
time did not seem to affect plasmid yield. Comparing 15 and 28 h of culture time within 
culture medium, pUC19 yield did not differ significantly (p > 0.05) in either TB broth 
cultures or LB broth cultures. The quality (estimated by the amount of end-product after 
PCR amplification) of pUC19 plasmid was not influenced by either culture media or 
culture time used. However, biotinylation conditions appeared to affect pUC19 fragment 
biotinylation efficiency. Incubation at 37 OC for 30 min seemed to increase biotinylation 
efficiency compared to 15 min either on ice or at room temperature. Additional research 
is needed to confirm this observation. 
Until recently, comparing DNA biotinylation efficiency under different 
conditions has been a painstaking process. Our novel membrane-based colorimetric 
procedure for testing pUC19 biotinylation efficiency was very effective, especially for 
side by side comparison, and was inexpensive and easy to perform. This procedure is 
useful not only for testing biotinylated DNA, but could potentially be used to test 
biotinylation efficiency in proteins. 
After optimizing the procedure of biotinylated pUC 19 production, we could 
detect as few as 48 PCR-generated or 5 Klenow fragment-generated biotinylated pUC19 
molecules in 50 p1 of imrnuno-PCR reaction. Only one-sixth of the total reaction volume 
(8 p1) was needed to detect a band on agarose gel. Based on these results, biotinylated 
pUC19 produced and tested using the optimized procedure may be used to enhance the 
sensitivity of our I-PCR assay. 
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Chapter 4 
Detection of Soluble and Membrane-Bound Antigens bv I-PCR 
Abstract 
Both soluble antigens and cell membrane-bound antigens were studied using 
ELISA and I-PCR assays. For the detection of bovine serum albumin molecules 
immobilized on microtiter plates, the detection limit of ELISA was 5.8 x lo7 molecules 
and the detection limit of I-PCR was 5.8 x 10' molecules, six orders of magnitude more 
sensitive than ELISA. For detecting recombinant interleukind molecules immobilized 
on microtiter plates, the detection limit of ELISA was 5.8 x 10'' molecules and the 
detection limit of I-PCR was 5.8 x lo3 molecules, seven orders of magnitude more 
sensitive than ELISA. I-PCR was also performed on individual mouse embryos using 
insulin receptors and EGF receptors on embryo plasma membranes as targets. In both 
cases, the intensity of the signal was positively correlated to the number of the embryos. 
The detection limit for insulin receptor was two embryos at the morula stage and the 
detection limit for EGF receptor was one embryo at the morula stage. Irnrnuno- 
polymerase chain reaction was also used to compare differences in H-2Db expression on 
embryos from two strains of mice, Balb/c (H-2Db negative) and C57BLl6 (H-2Db 
positive). Strong signals were detected from C57BLl6 mouse embryos, while signals 
were not detected from Balblc embryos. 
Introduction 
Bovine serum albumin immobilized on microtiter plates was detected by I-PCR 
in a classical experiment by Sano et al. (1992). The detection limit of BSA by I-PCR was 
5.8 x lo2 molecules, which was five orders of magnitude more sensitive than ELISA 
(5.8 x 10' molecules). This experiment was repeated in our lab in order to: 1) test 
ingredients produced in our lab for I-PCR, and 2) determine the relative sensitivity of 
I-PCR versus ELISA under our experimental conditions. 
Detection of IL-6 by I-PCR has never been reported in the literature. IL-6 belongs 
to a group of low-molecular-weight secretory proteins, collectively designated as 
cytokines, which have important hnctions in coordinating immune and inflammatory 
responses (Arai et al., 1990), in neuronal functions such as differentiation or survival 
(Gadient and Otten, 1995), and in growth signal transduction (Hibi et a]., 1990). 
Messenger RNA coding for IL-6 was detectable in human (Sharkey et al., 1995) and 
mouse embryos (Kita et al., 1994), which indirectly suggested that IL-6 played an 
important role in early embryonic development. In a preliminary study, we used 
recombinant IL-6 (mouse) immobilized on microtiter plates as target antigens. If I-PCR 
assay could detect IL-6 molecules with high sensitivity, our next step would be to 
determine whether IL-6 was secreted by preimplantation embryos and whether an I-PCR 
assay would be sensitive enough to detect IL-6 secretion by individual mouse embryos. 
Future research would be focused on determining embryo viability by measuring IL-6 
and other viability-related embryo products using I-PCR. 
There are only very limited data available that describe the detection of cell 
membrane-bound antigens on individual embryos by I-PCR. The first reported 
experiment was completed by McElhinny and Warner (1997). By using H - ~ D ~  
histocompatibility antigens as targets, they detected signal on individual mouse embryos 
at the blastocyst stage. Following this initial report, the usefulness of I-PCR was again 
demonstrated by this group for detecting other embryo surface antigens, including Qa-2 
protein, which increases the cleavage rate of mouse embryos (McElhinny et al., 1998a, 
1998b; Waner et al., 1993; Wu et al. 1999). Our objective was to use I-PCR to detect 
receptors for insulin and EGF on individual mouse embryos because these two proteins: 
1) have very important hnctions in cell signal transduction; 2) may be expressed by 
mouse embryos based on the reported expression of insulin receptor and EGF receptor 
mRNA in the inner cell mass (Harvey and Kaye, 1990; and 3) may have an expression 
pattern that is predictive of embryo viability (Heyner et al., 1989; Zhang et al., 1994). 
The objectives of the present studies were to: 1) validate the I-PCR technique in our lab 
by comparing I-PCR vs ELISA sensitivity in a 96-well plate-bound assay format using 
BSA as the target antigen; 2) detect a potential viability-related soluble protein by I-PCR 
and ELISA assay in a 96-well plate-bound assay format using recombinant IL-6 
molecules as the target antigens to determine absolute and relative sensitivities; and 3) 
detect the expression of viability-related cell-surface proteins on individual mouse 
embryos using an embryo I-PCR assay. 
Materials and Methods 
Reagents and Experimental Animals 
The following ingredients were from Sigma Chemical Co. (St. Louis, MO): 
recombinant Interleukin-6, bovine serum albumin, fatty acid free BSA (FAF-BSA), 
rabbit anti-mouse interleukin-6 (IgG fraction of antiserum), monoclonal anti- BSA 
(mouse IgG2a), biotinylated alkaline phosphatase, alkaline phosphatase yellow (pNPP) 
liquid substrate, sonicated salmon sperm DNA, equine chorionic gonadotropin (ECG), 
monoclonal anti-red blood cell (RBC) Wrb antigen (mouse, IgG2b), mineral oil, sodium 
penicillin G, streptomycin sulfate, gentarnycin sulfate, Dulbecco's phosphate buffered 
saline (DPBS). The following ingredients were from Gibco BRL (Grand Island, NY): 
dNTP mix, and platinumB Taq DNA polymerase. The following ingredients were from 
Biodesign International (Saco, Maine): monoclonal antibody (mouse IgGZb) to epidermal 
growth factor receptor, monoclonal antibody to mouse transfemn receptor (CD7 1, rat 
IgG2a). Anti-mouse H-2 D~ Ab (IgG2b) was from BD PharMingen (San Diego, CA). 
Gelatin was fiom Bio-Rad Laboratories (Hercules,CA); Ninety-six well plates (Maxisorp, 
flat bottom) were from Fisher Scientific and Fisherbrand Siliconized/Low Retention 
Microcentrifuge tubes with Snap Caps were from Fisher Scientific (Hanover Park, IL). 
C57BW6 mice were fiom Jackson Lab (Bar Harbor, ME). Balblc mice were from Charles 
River Laboratories (Wilmington, MA). The horizontal mini-gel system (model: MGU- 
202T) was from C.B.S. Scientific Company, Inc. (Del Mar, CA). 
ELISA Assav to Detect BSA and IL.-6 Immobilized onto the Surface of 96-well 
Microtiter Plates 
The BSA and IL-6 molecules on the surface of microtiter plates were detected 
using the assay method described by Sano et al. (1992). Our assay procedure, which 
included minor changes from the original procedure, was described briefly as follows: 
Preconiueation of Chimeric Protein with Biotinvlated Alkaline Phos~hatase. 
Fifty p1 of 8.5 x M chimeric protein solution in tris-buffered saline (TBS: 150 mM 
NaCl, 20 mM tris-HC1 at pH 7.5) with 0.02% sodium azide was mixed with 50 p1 
of 8.5 x lo6 M biotinylated alkaline phosphatase (in TBS with 0.02% sodium azide). 
The mixture was incubated at room temperature for one h. Just before use, 100 p1 of 
preconjugate was mixed with 4900 p1 of ETBS (TBS with 0.1 mM EDTA) at pH 7.5, 
containing 0.45% gelatin, to produce an 8.5 x lo-* M solution of conjugate. 
ELISA Assav. The surface of microtiter plate wells was coated with different amounts 
of FAF-BSA (from 5.8 x 1 0 ' ~  to zero molecules per well) or IL-6 (from 5.8 x 1012 to 
5.8 x lo7 molecules per well) in 50 pl of coating buffer at pH 9.5 [I50 mM NaCl, 20 mM 
tris-HC1, and 0.02% sodium azide] at 0 "C for 15 h to immobilize BSA or IL-6 molecules 
on the surface of the wells. The treatments of wells are shown in Table 4.1. Coated wells 
were washed four times for five min each with 150 p1 of TBS containing 0.02% sodium 
azide. After emptying the wells, 200 pl of ETBS containing 2% gelatin was added to 
each well and the plates were incubated at room temperature for one h to block reactable 
sites on the surface of the wells. After washing wells three times (five min each) with 
200 p1 of TETBS (ETBS with 0.04% Tween 20), 75 p1 of ETBS containing 0.45% 
gelatin and 500-fold diluted mouse monoclonal anti-BSA antibody or rabbit anti-mouse 
interleukin-6 antibody were added to wells. 
Table 4.1. Concentration of BSA or IL-6 (molecules/well) for ELISA assay. 
Well # 
Wells were incubated at room temperature for one h to allow the antibody to bind to 
immobilized BSA or IL-6 molecules. The wells were washed six times with 200 pl of 
TETBS. Six pmol of preconjugate of biotinylated alkaline phosphatase and streptavidin- 
protein A chimera in 70 p1 of ETBS containing 0.45% gelatin were added to each well 
and were incubated at room temperature for one h to allow the conjugate to bind to the 
antigen-antibody complexes. The wells were washed 10 times with 200 pl of TETBS and 
washed once with 200 pl of TBS without sodium azide. Two hundred pl of p-nitrophenyl 
phosphate (pNPP) was added to each well and was incubated at 37 O C  for up to one h. 
Concentration 1 
BSA IL-6 
The absorbance (at 405 nm) of each well was measured at 0, 15, 30,45, and 60 min after 
incubation. Fifty pl of 3N sodium hydroxide was added to the wells after 60 min of 
incubation to stop the reaction. 
Immuno-PCR Assay to Detect BSA and Recombinant I L 6  Molecules Immobilized 
onto the Surface of 96-Well Microtiter Plates 
BSA and IL-6 molecules on the surface of microtiter plates were detected using 
the assay method described by Sano et al. (1992). Only minor changes from the original 
protocol were included in the assay procedure, which is described briefly as follows: 
Preconiueation of Chimeric Protein with Biotinylated pUC19 Molecules. Protein A- 
streptavidin chimera and biotinylated pUC19 stock solutions were diluted and mixed in 
TBS solution (with sodium azide) at a concentration of 1.26 x 10-l2 M each. The mixture 
was incubated at room temperature for one h. Just before use, the mixture was hrther 
diluted with TETBS (containing 0.45% gelatin and 0.1 mg/ml sonicated salmon sperm 
DNA, pH 7.5) to a final concentration of 2.8 x 10-l4 M each. 
Immuno-PCR Assay. Wells of 96 well plates were coated with different amounts of 
BSA or recombinant IL-6 molecules (Table 4.2) in 50 p1 of coating buffer at 0 "C for 
15 h to immobilize BSA or IL-6 molecules on the surface of the wells. The wells were 
washed three times with 125 p1 and three times with 250 p1 of TBS with 0.02% sodium 
azide for five min each. Two hundred pl of ETBS containing 2% gelatin and 1 mg/mL of 
sonicated salmon sperm DNA were added to each well, and were incubated at 37 "C for 
80 min to block reactable sites on the surface of the wells. 
Table 4.2. Concentration of BSA or IL-6 (molecules/well) for I-PCR assay. 
The wells were washed three times with 200 pl and three times with 400 pl of 
TETBS (TBS with 0.1 mM EDTA & 0.1% Tween 20) by a plate washer. A volume of 
50 pl of TETBS [containing 0.1 mg/rnL of sonicated salmon sperm DNA, and 800,000- 
fold diluted mouse monoclonal anti-BSA or rabbit anti-mouse IL-6 antibody] was added 
to each well and incubated at room temperature for one h to allow the antibody to bind to 
immobilized BSA or IL-6 molecules. The wells were washed 30 times with 400 pl of 
TETBS. Fifty pl of TETBS (containing 0.45% gelatin, 0.1 mg/mL of sonicated salmon 
sperm DNA, and 2.8 x 10-l4 M of biotinylated pUC19 conjugated to the streptavidin- 
protein A chimera) were added to each well, which was then incubated at room 
temperature for 50 min to allow the conjugate to bind to the antigen-antibody complexes. 
The wells were washed 40 times with 400 pl TETBS and 6 times with 250 pl of TBS 
without sodium azide. Fifty pl of Master mix was added to each well and the plates were 
heated in a water bath at 85 OC for 10 min to disrupt antibody-antigen and antibody- 
chimeric protein bonds, thud releasing plate-bound biotinylated pUC 19 molecules into 
the Master Mix solution. The solution in each well was transferred into a thin-walled 
PCR tube. Polymerase chain reaction was performed with an automated thermal cycler 
(GeneAmp PCR System, Perkin Elmer, NorWalk, CT), with the use of the following 
temperature profile: initial denaturation at 94 OC for five min; 35 cycles of denaturation at 
94 OC for one min, annealing at 58 OC for one min, and extension at 72 OC for one min; 
and final extension at 72 OC for 5 min. The 21-mer primers (upper primer: 
SCAGGCAACTATGGATGAACGA'3 and lower primer: S'GGCGAAACCCGACAG- 
GACTAT3') hybridize to a segment of the biotinylated pUC19 fragment and generate a 
769-bp fragment upon PCR amplification. Eight p1 of PCR product and 2 p1 of gel 
loading solution were electrophoresed for 60 min at 95 Volts in a 1 .O% agarose gel. The 
intensity of 769 bp DNA bands on the agarose gel was viewed under ultraviolet light to 
determine the presence of PCR products. 
Immuno-PCR Assav to Detect Insulin Receptor and Epidermal Growth Factor 
Receptor on Mouse Embrvos 
Insulin receptors and EGF receptors on the plasma membranes of individual 
mouse morulae were detected with a modification of the method described by McElhinny 
and Warner (1997). Assay procedures were described briefly as follows: 
Mouse Superovulation. C57BU6 mice and Balblc mice (at 10 weeks of age) on a 12 h 
lightA2 h dark light cycle (lights on at 0600 h) were superovulated by ip injection at 
1300 h of 7.5 to 10 IU of eCG in normal saline. Forty-eight h after the eCG injection, 7.5 
to 10 IU of hCG was injected ip. Female mice were introduced to male mice 
immediately after the second injection, and were separated from males early the next 
morning. 
Mouse Embryo Recovery and Handlin~. Sixty-eight h after hCG treatment, 
superovulated female mice were killed by cervical dislocation. The ovaries and uteri were 
removed and were placed into drops of HEPES-buffered KSOM medium (pH 7.4) 
containing one mg/mL of BSA (Fraction V; HEPES-buffered KSOM) in Petri dishes at 
room temperature. The oviducts and uterine horns were flushed with the same medium 
to harvest embryos. High-quality embryos at the 8-cell stage or older were passed 
through eight drops of HEPES-buffered KSOM and one additional drop of bicarbonate- 
buffered KSOM medium (pH 7.35) containing one mg/mL of BSA (Fraction V; 
bicarbonate-buffered KSOM). Embryos were cultured overnight in 25 p1 drops of 
bicarbonate-buffered KSOM under mineral oil in 35 x 10 mm petri dishes at 37 OC with 
5% COz and maximum humidity. For some embryos, the zona pellucida was digested 
after three h of culture by incubating embryos in acidic Tyrodes solution (pH 2.5) for one 
min. Zona-fiee embryos were washed twice in Hepes-buffered KSOM and were 
transferred into bicarbonate-buffered KSOM drops, then were cultured overnight under 
the same conditions as stated above. 
Preconiu~ation of Biotinvlated pUC19 with Protein A-Streptavidin Chimera. A 
volume of 1.39 p1 of 1.44 x M pUC19 in modified Dulbecco's phosphate buffered 
saline (mdPBS) (0.49 mM MgC1,2.68 mM KC1, 1.47 mM KH2P04, 136.89 mM NaC1, 
8.10 mM Na2I-IP04,0.68 mM CaC1, one mg/mL glucose, 36 pg/mL pyruvic acid, 
60 pg/mL sodium penicillin, and 50 pg/mL strepton~ycin sulfate) at pH 7.5 was mixed 
with 0.76 pl of 2.62 x M protein A-streptavidin chimera in mdPBS. The mixture was 
incubated at room temperature for one h. Just before use, the preconjugate was diluted 
with 500 pl of dilution buffer (mdPBS at pH 7.5 containing 0.5% FAF-BSA, 0.1 % 
sodium azide, 25 pg/mL of gentamycin and 0.1 mg/mL of sonicated salmon sperm DNA) 
to obtain a final pUC 19fchimera concentration of 4.0 x lo-'' M. 
Immuno-PCR of Mouse Embryos. After incubation overnight, zona-free embryos at the 
compact morula to blastcyst stage were rinsed in four drops of mdPBS containing 0.5% 
of FAF-BSA, 0.1% of sodium azide, and 25 pg/mL of gentamycin (Wash solution 11). 
Embryos were incubated in 30 p1 of diluted antibody solution [mixing 15 p1 of original 
antibody solution (anti-H-2 D~ at 250 pg/mL, anti-insulin receptor at 250 pg/mL) and 
15 p1 of the Wash Solution II] or 30 p1 of undiluted antibody solution (anti EGF-R at 
8 
100 pg/ml) for four hours on ice. The embryos were washed six times in mdPBS 
containing 0.5% FAF-BSA, 0.1% sodium azide, 0.002% tween 20, and 25 pg/mL of 
gentamycin (Wash Solution I) and then six times in Wash Solution II. Embryos were 
transferred into 50 pl of 4.0 x lo-" M chimeric protein/ biotinylated pUC19 conjugate in 
mdPBS containing 0.5% of FAF-BSA, 0.1% salmon sperm DNA, 0.1% sodium azide and 
25 pg/mL gentamycin, and were incubated for one h on ice. Embryos were washed in six 
drops of wash solution I and then six drops of wash solution 11, then were rinsed briefly 
in two drops of sodium azide-free mdPBS containing 0.5% FAF-BSA, then were 
transferred into thin-wall PCR tubes containing 3 p1 of distilled water. After adding 
48 p1 of Master Mix, PCR was performed under the same conditions as used for the 
amplification of BSA and recombinant IL-6. Bands of amplified pUC19 were visualized 
by ultraviolet light. 
Stasistical Analysis 
The data generated in these experiments were analyzed by Student's t-test or by 
Analysis of Variance. 
Results and Discussion 
LISA and I-PCR Detection of BSA Immobilized on Microtiter Plates 
The results of BSA detection by ELISA are presented in Figure 4.1. When 
5.8 x lo7 or more BSA molecules were used, the absorbances at 405 nrn were all 
significantly higher (p < 0.05) than when the wells received 5.8 x lo7 or fewer molecules 
of BSA. The absorbances were not significantly different among the wells that received 
5.8 x lo6 or fewer BSA molecules. The absorbances fell into a linear range when the 
amount of BSA was between 5.8 x 10'' and 5.8 x 10~molecules. The detection limit of 
the ELISA assay for BSA was 5.8 x lo7 molecules per well. 
The results of BSA detection by I-PCR are presented in Figure 4.2. As the 
concentration of coating antigens was reduced fiom 5.8 x 1 o4 molecules (Lane 2) to 
5.8 x 10' molecules (Lane 9, the pUC19 band was clearly detectable by I-PCR, and its 
intensity decreased in a dose-dependent manner. When the concentration of BSA 
molecules was reduced to 5.8 x 10' molecules (Lane 6) per well, the signal was no longer 
detectable by I-PCR. The signal lessened sharply when the number of BSA 
molecules was reduced fiom 5.8 x lo2 (Lane 4) molecules to 5.8 x 10' (Lane 5) 
molecules. 
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Figure 4.1. BSA detection by ELISA. The surface of microtiter plate wells was coated 
with different amounts of BSA at 0 "C for 15 h. After the wells were washed with TBS, 
reactable sites on the surface of the wells were blocked with 2% gelatin in ETBS at room 
temperature for 1 h. After washing wells with TETBS, mouse monoclonal anti-BSA 
antibody in ETBS containing 0.45% gelatin was added to the wells and was incubated at 
room temperature for 1 h. After washing wells, a conjugate of 6 pmol of biotinylated 
alkaline phosphatase and the streptavidin-protein A chimera in ETBS containing 0.45% 
gelatin was added to each well and was incubated at room temperature for 1 h. The wells 
were washed with TETBS first and then with TBS without sodium azide. P-nitrophenyl 
phosphate (pNPP) substrate was added to each well and was incubated at 37 "C for up to 
1 h. Absorbances at 405 nm was measured at 0,15,30,45, and 60 min of incubation. 
N*-Negative control, no BSA molecules coated on the well. 
Figure 4.2. BSA detection by immuno-PCR. Microtiter plate wells were coated with 
different amounts of BSA at 0 O C  for 15 h. Reactable sites on the surface of the wells 
were blocked with ETBS containing 2% gelatin and one mg/mL of sonicated salmon 
sperm DNA. Mouse monoclonal anti-BSA in TETBS containing 0.1 mg/mL of sonicated 
salmon sperm DNA was added to each well and was incubated at room temperature for 
one h. This was followed by adding biotinylated pUC 19 conjugated to streptavidin- 
protein A chimera in TETBS (containing 0.45% gelatin and 0.1 mg/mL of sonicated 
salmon sperm DNA). Wells were incubated at room temperature for 50 min. Fifty uL of 
Master Mix was added to each well and the plates were heated at 85 OC for 10 min. The 
solution in each well was transferred to a thin-walled PCR tube. PCR products were 
loaded into wells of an agarose gel. The DNA band intensity on the agarose gel was 
viewed under UV-light and photographed. Lane M, DNA ladder; Lane 1, ositive control a (2 p1 of 1.4 x 1 0-13 M of biotinylated pUC 19; Lanes 2 through 6,5.8 x 10 to 5.8 x 10' 
molecules of BSA per well. 
Immuno-PCR was 1.0 x lo6 times more sensitive than the comparable ELISA 
assay for detecting BSA molecules on the surface of microtiter plates (5.8 x 10' versus 
5.8 x lo7 molecules, respectively). The ELISA results were similar to those obtained by 
Sano et al. (1992), who also reported a sensitivity of 5.8 x 107m~lecule~ of BSA with an 
ELISA. However, our I-PCR detection limit of 5.8 x 10' BSA molecules, was 10 times 
more sensitive for the detection of plate-bound BSA than Sano's (5.8 x lo2 molecules). 
The reason for the increased sensitivity in our assay is not completely understood. Our 
more stringent washings and 100-fold lower antibody concentration may have 
contributed to the increased sensitivity by reduction of the background signal. 
Detection of Recombinant IL-6 on Microtiter Plates bv ELISA and I-PCR 
The results of IL-6 detection by ELISA are presented in Figure 4.3. When 
5.8 x 10" or more IL-6 molecules were used, the absorbances at 405 nrn were all 
significantly higher (p < 0.05) than that obtained from the wells that received 5.8 x lo9 or 
fewer IL-6 n~olecules. 
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Figure 4.3. IL-6 detection by ELISA. The surface of microtiter plate wells was coated 
with different amounts of IL-6 at 0 OC for 15 h. After the wells were washed with TBS, 
the reactable sites on the surface of the wells were blocked with 2% gelatin in ETBS at 
room temperature for 1 h. After washing wells with TETBS, mouse monoclonal anti- 
BSA antibody in ETBS containing 0.45% gelatin was added to the wells and incubated at 
room temperature for 1 h. After a second series of washes, a conjugate of 6 pmol of 
biotinylated alkaline phosphatase and streptavidin-protein A chimera in ETBS containing 
0.45% gelatin was added to each well and was incubated at room temperature for 1 h. 
The wells were washed with TETBS and then with TBS without sodium azide. 
P-nitrophenyl phosphate (pNPP) substrate was added to each well and was incubated at 
37 OC for up to 1 h. The absorbance at 405 nm was measured at 0,15,30,45, and 60 min 
after incubation. 
The absorbances were not significantly different among the wells that received 5.8 x lo9 
or fewer BSA molecules. The detection limit of the ELISA assay for IL-6 was 5.8 x 10" 
molecules. 
The results (one of the triplicate gels) of IL-6 detection by I-PCR are presented in 
Figure 4.4. When the coating antigens were reduced fiom 5.8 x 10' (Lane 2) to 5.8 x lo3 
(Lane 6) molecules/well, the PCR bands were visible, and decreased in intensity in a 
linear manner. Repeatable band patterns (in triplicates) were obtained. 
Figure 4.4. IL-6 detection by immuno-PCR. The microtiter plate wells were coated with 
different amounts of IL-6 at 0 OC for 15 h. The reactable sites on the surface of the wells 
were blocked with ETBS containing 2% gelatin and one mg/mL of sonicated salmon 
sperm DNA. The mouse monoclonal anti-IL-6 in TETBS containing 0.1 mg/mL of 
sonicated salmon sperm DNA was added to each well and was incubated at room 
temperature for one h. This was followed by adding biotinylated pUC19 conjugated to 
the streptavidin-protein A chimera in TETBS (containing 0.45% gelatin, 0.1 mg/mL of 
sonicated salmon sperm DNA) to each well and incubated at room temperature for 50 
min. After washing, fifty microliters of Master Mix was added to each well and the 
plates were heated at 85 OC for 10 min. The solution in each well was transferred into a 
thin-walled PCR tube. After PCR amplification, the PCR products were loaded into each 
well of an agarose gel. The DNA band intensity on the agarose gel was viewed under 
ultraviolet li t and photographed. Lane M, DNA ladder; Lane 1, positive control (2 pl P of 1.4 x lo-' M of biotinylated pUC 19; Lanes 2 through 7, 5.8 x 10' to 5.8 x 1 o3 
molecules of IL-6 per well. 
When IL-6 was reduced to 5.8 x lo2 molecules/well (Lane 7), the I-PCR signal 
was no longer detectable. Although the absolute sensitivity of I-PCR for detecting IL-6 
was not as high as for BSA, its relative sensitivity (in comparison to ELISA) was higher 
compared to the BSA. The I-PCR achieved seven orders of magnitude more sensitivity 
than ELISA for detecting immobilized IL-6 molecules compared to six orders of 
magnitude more sensitivity obtained in the BSA assays. The reason for the lower absolute 
sensitivity of the IL-6 I-PCR may be attributable to the presence of a 50-fold excess of 
BSA in the IL-6 sample. BSA molecules may have competed with IL-6 molecules for the 
limited binding sites on the surface of the microtiter plate well and therefore may have 
reduced the absolute number of IL-6 molecules that bound to the wells. 
Detection of Insulin Receptors and EGF Rece~tors on Mouse Embrvos by I-PCR 
Figure 4.5 presents results that were typical of our early efforts to use I-PCR 
assay to detect cell surface markers on C57BLl6 mouse blastocysts. After zona-free 
embryos from C57BLl6 mice were cultured overnight and rinsed in three drops of 
mdPBS containing 1% BSA and 0.1% sodium azide, they were incubated on ice for one h 
in a mixture of diluted antibodies [two ul of each of eight antibodies plus eight-four p1 of 
n1dPBS (containing 0.1% sodium azide), so, each antibody was diluted 50 fold]. The 
antibodies were: 1) monoclonal antibody to epidermal growth factor receptor, IgGzb 
(mouse), 0.25 pg/mL, Biodesign InternationalTM; 2) monoclonal antibody to transferrin 
receptor, IgG2, (rat), 1.25 pg/mL, Biodesign InternationalTM; 3) monoclonal antibody to 
integrin a 5  chain , IgG2,, K (rat), 1.25 pg/mL, BD PharMingen; 4) monoclonal antibody 
to integrin p l  chain , IgG2,, K (rat), 0.25 pg/mL, BD PharMingen; 5) monoclonal 
antibody to hyaluronate receptor, IgGZb, K (rat), 1.25 pg/mL, BD PharMingen; 
6) monoclonal antibody to H - ~ D ~ ,  IgGZb, K (mouse), 1.25 pg/mL, BD PharMingen; 
7) monoclonal antibody to Qa-2, IgG2,, K (mouse), 0.25 pg/mL, BD PharMingen; and 
8) monoclonal antibody to E-Cadherin, IgG2,, (mouse), 0.625 pg/mL, Sigma Chemical 
Co. Embryos were washed in five drops of 100 p1 of mdPBS (1 % BSA, 0.1 % sodium 
azide, and 0.02% tween 20) (Wash I) and five drops of mdPBS (1% BSA and 0.1% 
sodium azide) (Wash 11), then were incubated in protein A-streptavidin chimera that was 
diluted to 1 x lo-" M in Wash II. After washing with five drops each of Wash I and 
Wash 11, embryos were incubated in 4 x lo-" M biotinylated pUC 19 fragments. After 
washing as above to remove unbound biotinylated pUC 19 molecules, mouse embryos 
were transferred into thin-walled PCR tubes containing 3 ul of distilled water. Fifty 
microliters of Master Mix was added to each tube. After PCR amplification, PCR 
products were resolved on agrose gels and were visualized over ultraviolet light. No 
band was observed in the negative control lane (Lane 2). When one embryo (Lane 7) was 
incubated with a mixture of antibodies, only a very weak band was seen on the gel. The 
band became brighter when six embryos (Lane 6) were used. The brightest band (except 
positive control, Lane 1) was obtained when antibodies were excluded from the assay 
(Lane 5). The second brightest band was obtained when both antibody mixture and 
protein A-streptavidin chimera were excluded from the assay (Lane 4). Based on these 
inconsistent results we hypothesized that the background signals (without antibodies or 
without either antibodies and protein A-streptavidin chimera) were too high and this 
masked the specific signals. 
Figure 4.5. Surface antigen detection on C57/BL6 mouse blastocysts by I-PCR assay. 
After zona-free embryos were cultured overnight and rinsed in mdPBS once, they were 
incubated in a mixture of antibodies for one h on ice. After washing, embryos were 
incubated in chimeric protein and biotinylated pUC19 for one h each under the same 
conditions. After washing, mouse embryos were transferred into thin-walled PCR tubes 
and fifty microliters of Master Mix was added to each tube. The PCR product was 
resolved on agrose gel and visualized over ultraviolet light. Lane M, DNA ladder; Lane 
1,2 ul of 4 x lo-" M biotinylated pUC19 fragments put directly in PCR tube (positive 
control); Lane 2,2 p1 of PBS put directly in PCR tube (negative control); Lane 3, without 
antibodies, without protein A-streptavidin chimera, without biotinylated pUC19 (with 3 
blastocysts); Lane 4, without antibodies, without protein A-streptavidin chimera, with 
biotinylated pUC19 (4 x lo-" M) (with 2 blastocysts); Lane 5, without antibodies, with 
protein A-streptavidin chimeria, with biotinylated pUC19 (4 x lo-" M) (2 blastocysts); 
Lane 6, with antibody mixture, with protein A-streptavidin chimera, with biotinylated 
pUC19 (4 x lo-" M) (6 blastocysts); Lane 7, with antibody mixture, with protein A- 
streptavidin chimera, with biotinylated pUC19 (4 x 10'" M) (1 blastocyst); Lane 8,3  p1 
of last embryo rinse put directly in PCR tube; and Lane 9, Master Mix only without PCR 
amplification. 
McElhinny and Warner (1997) used a n t i - ~ 2 - ~ ~  antibody and 10-l3 M pUC19 in their 
embryo I-PCR assay and reported a visible signal with single embryo sensitivity. 
However, when we followed their protocol exactly, we were unable to duplicate their 
results in our lab. We also performed embryo I-PCR assays using other antibodies for 
mouse embryo surface antigens, again following the published procedure, but no signal 
was obtained. Two possible reasons might have accounted for our failure to produce a 
signal: 1) biotinylated pUC19 concentration in our assay was too low, andfor 2) the 
concentrations of target antigens on embryos were too low to be detectable. In order to 
test the first possibility, we increased the concentration of biotinylated pUC19 in our 
assay from 4 x 10-l3 M to 4 x lo-'' M. To test the second possibility, we incubated 
embryos with a mixture of eight antibodies (to increase the number of targets) instead of 
one antibody in our current I-PCR assay. However, this gave us very high background 
signals. In order to reduce or eliminate this high background signal, sonicated salmon 
sperm DNA was added to both chimeric protein and biotinylated pUC19 incubation step, 
so that the non-specific binding of DNA to embryos was blocked. 
The results of detecting insulin and EGF receptors on BALBlc mouse morulae by 
I-PCR assay were presented in Figure 4.6. The pivotal discovery in this study is that the 
nonspecific signal o f "  no antibody negative control " (Lane 4) was decreased to an 
undetectable level by the addition of 0.1 mglmL of sonicated salmon sperm DNA to the 
incubation steps of antibody, chimeric protein, and biotinylated pPC19. Because the 
background signal no longer obscured specific binding of pUC19 to embryo-bound 
antibody, the target signals were revealed (Lanes 6 and 7). While insulin and EGF 
receptors both appeared to be expressed by Balblc mouse morulae, CD7 1 molecules did 
not seem to be expressed at a detectable level on these embryos at the morula stage 
(Lane 8). An unexpected finding was that the zonae pellucida of mouse embryos did not 
trap significant amounts of the conjugate of protein A-streptavidin chimera and 
biotinylated pPC19 (Lane 9). This finding was not consistent with experimental results 
obtained by another research group (Warner, 1998), and may be due to the blocking 
action of sonicated salmon sperm DNA. 
Figure 4.6. Detection of insulin receptor and EGF receptor on Balblc mouse morulae by 
I-PCR. Zona-free embryos were cultured overnight, then were washed in mdPBS, then 
were incubated with or without antibodies on ice for three h. After washing to remove 
unbound antibodies, embryos were incubated with or without 4 x lo-" M of chimeric 
protein/ biotinylated pUC19 conjugate for one h on ice. After washing to remove the 
unbound conjugate, embryos were transferred into thin-walled PCR tubes containing 3 p1 
of distilled water and 50 p1 of Master Mix was added to each tube. The PCR product was 
resolved on an agrose gel and was visualized over ultraviolet light. Lane M, DNA 
ladder; Lane 1 ,2  pl of 1.4 x loL3 M biotinylated pUC19 fragments put directly in PCR 
tube (positive control); Lane 2,2 p1 of PBS put directly in PCR tube (negative control); 
Lane 3, without antibody, without protein A-streptavidin chimera, without Marker DNA, 
with 5 morulae (embryo negative control); Lane 4, without antibody, with protein A- 
streptavidin chimera, with biotinylated pUC19, with 5 morulae (antibody-free negative 
control); Lane 5, with anti-Red Cell Wrb antibody, with protein A-streptavidin chimera, 
with biotinylated pUC19, with 4 morulae (negative antibody control); Lane 6, with anti- 
insulin receptor antibody, with protein A-streptavidin chimera, with biotinylated pUC19, 
with 6 morulae; Lane 7, with anti-EGF receptor antibody, with protein A-streptavidin 
chimera, with biotinylated pUC19, with 5 morulae; Lane 8, with anti-CD71 antibody, 
with protein A-streptavidin chimera, with biotinylated pUC19, with 5 morulae; Lane 9, 
without antibody, with protein A-streptavidin chmera, with biotinylated pUC19, with 4 
zona-enclosed expanded blastocysts; and Lane 10,3 p1 of fluid from the last embryo 
rinse of the negative antibody control treatment. 
Another unexpected finding was obtained when anti-Red Cell Wrb antibody was used in 
the assay. Because Red Cell Wrb antigen was supposed to be expressed only on red 
blood cells (Telen and Bolk, 1982; Telen et al., 1987), we used it as a negative antibody 
control in the present I-PCR assay. However, anti-RBC Wrb antibody produced a 
positive signal in the I-PCR (Lane 5). The reason for this unexpected result is beyond 
our comprehension, but may be due to cross-reactivity of the anti-RBC Wrb antibody 
with embryo surface proteins. Based on this result, we discontinued our use of anti-RBC 
Wrb antibody as a negative antibody control in our later experiments. 
In later studies, we included a strain-specific histocompatibility antibody, 
anti-H-2 Db antibody, as both a negative antibody control (when incubated with embryos 
from a H-2 Db negative mouse strain (Balblc) and a positive antibody control (when 
incubated with embryos fiom a H-2 Db positive mouse strain (C57BLl6). Since very 
strong signals were obtained with anti-insulin receptor (Lane 6) and anti-EGF receptor 
(Lane 7) antibodies in this study, we also explored the possibility of using fewer embryos 
per incubation in later studies. 
Our final I-PCR experiment utilized antibodies against H - ~ D ~  antigen, insulin 
receptor, and EGF receptor and each antibody was incubated with one to six BALBIc or 
C57BW6 mouse morulae. Results are presented in Figure 4.7. 
When anti-insulin receptor antibody was used, the PCR band was fairly intense 
for 5 embryos (Lane lo), clearly observable for two embryos (Lane 1 I), and not 
detectable for one embryo (Lane 12). When anti-EGF receptor antibody was used, the 
PCR band was very strong for six embryos (Lane 13), fairly strong for three embryos 
(Lane 14), and clearly above background for one embryo (Lane 15). When Anti HZ-D~ 
antibody was used for detecting target antigen on BALBIc embryos which are negative 
for this antigen (BD PharMingen, 2000), the signal was very weak even using six 
embryos (Lane 4), barely observable for three embryos (Lane 5), and completely absent 
for one embryo (Lane 6). When Anti H-2 Db antibody was used for detecting target 
antigen on C57BL6 mouse embryos [positive for H-2 Db molecules (McElhinny and 
Warner, 1997)], a different picture appeared: the signal was extremely strong for six 
embryos (Lane 7), strong for three embryos (Lane 8), and clearly above background for 
one embryo (Lane 9). Consequently, the anti- H ~ - D ~  antibody was successfully used as 
both a positive and a negative control. 
Figure 4.7. Detection of H-2 Db molecules, insulin receptor, and EGF receptors on 
C57BLl6 and Balblc mouse morulae by I-PCR. Zona-free embryos were cultured in 
KSOM medium overnight, then were washed in mdPBS, and then were incubated in a 
solution with or without respective antibody for three h on ice. After removing unbound 
antibodies by washing, embryos were incubated in a solution with or without the 
conjugate of protein A-streptavidin chimera and biotinylated pUC 19 for 1 h on ice. After 
washing to remove the unbound conjugate, mouse embryos were transferred into thin- 
walled PCR tubes that contained three p1 distilled water and forty-eight microliters of 
Master Mix was added to each tube. The PCR products were resolved on agarose gel and 
were visualized under ultraviolet light. Lane M, DNA ladder; Lane 1,2  p1 of 1.4 x 1 0-l3 
M biotinylated pUC19 fragments put directly in PCR tube (positive control); Lane 2,3 p1 
of mdPBS put directly in PCR tube (negative control); Lane 3, without antibody, with 
protein A-streptavidin chimera, with 4 x 10"' M biotinylated pUC 19 fragments (Marker 
DNA), with 6 Balblc morulae (antibody-free negative control); Lanes 4 through 6, anti- 
H-2 Db antibody, with protein A-streptavidin chimera, with Marker DNA, with 6,3, or 1 
morulae from Balblc mice, respectively; Lanes 7 through 9, with anti-H-2 Db antibody, 
with protein A-streptavidin chimera, with Marker DNA, with 6,3, or 1 morulae from 
C571BL6 mice, respectively; Lanes 10 through 12, with anti-insulin receptor antibody, 
with protein A-streptavidin chimera, with Marker DNA, with 5,2, or 1 morulae from 
Balblc mice, respectively; Lanes 13 through 15, with anti-EGF receptor antibody, with 
protein A-streptavidin chimera, with Marker DNA, with 6,3, or 1 morulae from Balblc 
mice, respectively. 
To our surprise, cell surface antigens on a single embryo at the morula stage could 
be detected by I-PCR assay. This is very significant in terms of the sensitivity of our 
modified I-PCR technique for detecting cell surface antigen. Previously, the highest 
sensitivity with I-PCR for detection of mouse embryo surface antigens was reported by 
McElhinny and Warner (1 997) on a single mouse embryo at the blastocyst stage, which 
contains more cells than a morula-stage embryo. 
Summary 
Both soluble and membrane-bound antigens were successhlly detected by I-PCR 
technique. The soluble antigens were BSA and IL-6 molecules and the membrane-bound 
antigens were insulin receptor, EGF receptor, and H-2 D~ histocompatibility antigens on 
mouse embryos. Plate-based I-PCR of soluble BSA and IL-6 demonstrated much higher 
sensitivity in comparison to assays of these compounds using ELISA. 
The detection of BSA fixed on microtiter plates has been reported previously 
(Sano et al., 1992), but we chose to repeat this classic experiment in order to demonstrate 
that our protein A-streptavidin chimera and biotinylated pUC 19 were hlly hnctional. 
For purposes of comparing relative sensitivity with a known assay, ELISA and I-PCR for 
plate-bound BSA molecules were performed concurrently. The detection limit of ELISA 
on plate-bound BSA was 5.8 x 10' molecules. This result is exactly the same as obtained 
by Sano et a1 (1992). The detection limit of I-PCR was 5.8 x 10' molecules. Our 
sensitivity was 10 times higher than the sensitivity reported by Sano et a1 (1992), which 
was 5.8 x lo2 molecules. This high detection sensitivity (six orders of magnitude higher 
than ELISA) of BSA by I-PCR has hrther proved that our protein A-streptavidin chimera 
and biotinylated pUC 19 were hlly functional. In addition, these results also 
demonstrated that Sano's I-PCR technique worked under the conditions in our laboratory. 
Plate-bound IL-6 was also detected by I-PCR and ELISA. The detection limit of 
I-PCR for IL-6 was 5.8 x lo3 molecules. The absolute sensitivity of I-PCR for IL-6 was 
2 orders of magnitude lower than for BSA. The detection limit of ELISA for IL-6 was 
5.8 x 101° molecules, which was three orders of magnitude lower than for BSA. The 
reduced sensitivity for IL-6 molecules might be due to the "carrier" protein (BSA, at 50 
times the concentration of IL-6) in the commercial preparation of IL-6. The 
overwhelming number of BSA to IL-6 molecules may have reduced the number of IL-6 
molecules bound to the surface of microtiter plate wells because of competition between 
BSA and IL-6 for limited number of binding sites. Although the absolute detection limit 
of I-PCR for IL-6 was lower than I-PCR for BSA, the relative sensitivity of I-PCR for 
IL-6 (compared to IL-6 ELISA assay) was seven orders of magnitude higher than that of 
IL-6 ELISA assay and was one order of magnitude more sensitive than the relative 
sensitivity of I-PCR for BSA. These results have demonstrated that I-PCR is preferable 
method to ELISA for the detection of a soluble antigen in a impure sample. 
Detecting cell surface proteins on embryos by I-PCR was the most challenging 
application of I-PCR technology. By using an existing published protocol fiom the other 
lab, we were unable to obtain PCR signals after incubation of mouse embryos with 
antibodies to putative embryo antigens. However, by increasing the concentration of 
protein A-streptavidin and biotinylated pUC 19 conjugate fiom 4 x 1 013 M to 4 x 10" M, 
we produced strong signals, but simultaneously increased non-specific binding enough to 
mask the specific signal. The increased background made the I-PCR useless for the 
identification of the target antigens. Based on numerous unsuccessfiil embryo-I-PCR 
assays using the original published I-PCR protocol, we hypothesized that an unacceptably 
high level of non-specific binding was overshadowing any signal generated by specific 
antibody-antigen binding. In an attempt to solve this problem, we kept the conjugate 
concentration at the same level, but added sonicated denatured salmon sperm DNA (to 
reduce non-specific binding of pUC19 to embryos) to incubation drops that contained 
biotinylated pUC19. This change allowed us to increase the concentration of protein A- 
streptavidin.biotiny1ated pUC 19 conjugate by a factor of 100, while reducing non- 
specific binding of pUC19 to undetectable levels. 
The embryo surface proteins of interest were insulin receptor, EGF receptor, and 
H-2 Db molecules. We chose to use anti- H-2 Db antibody as both a positive and a 
negative control since the existing data demonstrated that H-2 Db molecules were 
expressed only on C57IBL6 mouse embryos, but not on Balblc embryos (BD 
PharMingen, 2000). Our I-PCR results confirmed these earlier findings: H-2 Db 
molecules existed only on C57BU6 mouse embryos, but not on Balblc embryos. 
By using I-PCR technique, we were able to detect positive signals on two mouse embryos 
at the morula stage by using antibody to insulin receptor, and on only one mouse embryo 
at the morula stage by using antibody to EGF receptor. Such a high sensitivity of 
detecting cell surface antigens expressed on mammalian embryos has not previously been 
reported. This result demonstrated that I-PCR is a very powerful and a very useful 
technique for detecting cell surface antigens on embryos. 
Our experimental results demonstrated that I-PCR is the most sensitive technique 
for detecting both soluble and membrane-bound antigens. Comparing to ELISA, I-PCR 
was six orders of magnitude more sensitive for detecting BSA molecules and seven 
orders of magnitude more sensitive for detecting IL-6 molecules. The detection limit for 
insulin receptor was two embryos at the morula stage and the detection limit for EGF 
receptor was one embryo at the morula stage. Because IL-6 molecules, insulin receptors, 
and EGF receptors are viability-related embryo proteins, I-PCR assay may become a 
potential technique for the testing of embryo viability. 
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Chapter 5 
SUMMARY 
Protein A-streptavidin chimera was one of the important components used in 
I-PCR. Experiments were conducted to increase the yield of this protein through 
modifications to the original protocol. A number of factors were studied and several of 
them were demonstrated to play a role in the yield of this protein. The protein yield was 
increased substantially by using the newly optimized protocol. Experiments were also 
conducted to test the binding of this protein to both antibodies and biotinylated DNA, and 
its physical and fbnctional integrity were confirmed by these studies. 
The yield of protein A-streptavidin chimera increased from zero to four h after 
IPTG induction. Under our experimental conditions, the optimal induction time was four 
hours. IPTG induction temperature did not appear to affect the yield of Protein A- 
streptavidin chimera, while culture medium had a significant effect on the yield of 
Protein A-streptavidin chimera. The yield was five to ten times higher when E. coli cells 
were cultured in TB broth than in either LB broth or M9 medium. This increased 
bacterial yield did not seem to result from increase bacterial density alone because 
the yield of plasmid was increased by TB broth even when the effect of bacterial 
concentration was equalized among treatment groups. The strong buffer system in 
TB broth may have played a role in its superior growth-promoting effect. 
The methods used for bacterial cell lysis and protein purification also affected 
the chimeric protein yield. Lysing by sonication appeared to be superior in terms of 
chimeric protein yield compared to chemically induced lysis. More than three times as 
much protein A-streptavidin chimera was obtained when a centrifugation step just before 
biotin affinity chromatography was eliminated. Both immuno-blotting and ELISA assays 
were used to test the functional status of the protein A-streptavidin chimera. By immuno- 
blotting, a single band of approximately 3 1 kd was obtained. In an ELISA assay, 
the intensity of color depended on the antigen concentration in a dose-dependent manner. 
These data suggested that our protein A-streptavidin chimera was fully functional. 
The factors affecting pUC19 plasmid yield from pUC19-transformed E. coli cells 
were studied in a series of experiments. The yield of pUC19 plasmid was almost doubled 
(p < 0.05) when TB broth rather than LB broth was used to culture transformed bacteria. 
Culture time did not affect plasmid yield. The quality of pUC19 plasmid was not 
influenced by either culture media or culture time used. However, biotinylation 
conditions appeared to affect pUC 19 fragment biotinylation efficiency. Incubation 
at 37 OC for 30 min seemed to increase biotinylation efficiency compared to incubation 
for 15 min either on ice or at room temperature. A novel membrane-based colorimetric 
technique for testing the efficiency of pUC19 biotinylation was described. It was very 
effective, especially for side by side comparison, and inexpensive and easy to perform 
compared to presently available procedures. Our results indicated that the efficiency of 
pUC19 fragment biotinylation by biotinylated primer did not appear to be superior to 
Klenow fragemen-catalyzed insertion of biotin-dATP. Our membrane-based colorimetric 
technique is useful not only for testing biotinylated DNA, but could potentially be used to 
test biotinylation efficiency in proteins. After developing an optimized PCR procedure, 
we could detect as few as 48 PCR-generated or 5 Klenow fragment-generated 
biotinylated pUC 19 molecules in 50 pl of I-PCR reaction. Only one-sixth of the total 
reaction (8 pl) was needed to detect a band on agarose gel. Based on these results, 
biotinylated pUC 19 produced and tested using the optimized procedure may be used to 
enhance the sensitivity of our I-PCR assay. 
I-PCR technique was used to detect BSA and IL-6 soluble antigens. I-PCR 
demonstrated much higher sensitivity than ELISA for the detection of these antigens. The 
detection limit of I-PCR for BSA was 5.8 x 10' molecules which was six orders of 
magnitude more sensitive than ELISA. The detection limit of irnmuno-PCR for IL-6 was 
5.8 x lo3 molecules, which was seven orders of magnitude more sensitive than that of 
ELISA for IL-6. These results have demonstrated that; 1) I-PCR is a more sensitive 
method than ELISA for the detection of a soluble antigen; and 2) our protein A- 
streptavidin chimera and biotinylated pUC19 were fully functional 
I-PCR was also used to detect insulin receptor, EGF receptor, and H-2 Db 
molecules that were expressed on the plasma membranes of murine embryos. By using 
I-PCR technique, we were able to detect positive signals on as few as two mouse 
embryos at the morula stage by using antibody to insulin receptor, and on only one mouse 
embryo at the morula stage by using antibody to EGF receptor. Such a high sensitivity of 
detecting embryo natural surface antigens has not previously been reported. 
Two breakthroughs were made in studying membrane-bound antigens by I-PCR 
technique. The first was our decision to include denatured salmon sperm DNA to reduce 
non-specific binding of pUC19 to embryos. The second was to use anti-H-2 Db antibody 
as both a positive and a negative, strain-specific experimental controls. These 
modifications increased our ability to generate meaningful experimental data with the n 
I-PCR assay. Originally, 4 x 1 0-l3 M of biotinylated pUC 19 molecules were used in the " 
I-PCR for detecting membrane-bound antigens on mouse embryos, and a positive signal 
was never obtained. By increasing the concentration of biotinylated pUC 19 from 4 x 10-l3 
M to 4 x lo-" M, strong signals were generated, but meanwhile the background signal 
was so high that it masked any specific binding to the target antigen. In an attempt to 
solve this problem, we used a biotinylated pUC 19 concentration of 4 x lo-" M, but added 
0.1 m g h L  sonicated salmon sperm DNA as a blocking agent in the antibody and pUC19 
incubations. This change allowed us to increase biotinylated pUC19 concentration by a 
factor of 100 (to 4 x 10-l1 M), while reducing non-specific binding of pUC19 to 
undetectable levels. We also used embryos from both H-2 Db positive (C57BLl6) and 
H-2 Db negative (Balblc) strains of mice. This combination allowed us to use anti-H-2 Db 
antibody as both a positive and a negative control. A positive signal was detected on the 
embryos of C57/BL6 mice and no signal was detected on the embryos of Balblc mice by 
I-PCR assay. 
I-PCR is the most sensitive technique for detecting both soluble and membrane- 
bound antigens. By using this technique, we obtained six orders of magnitude more 
sensitivity for detecting BSA molecules and seven orders of magnitude more sensitivity 
for detecting IL-6 molecules than using ELISA. In addition, we were able to detect 
signals on two morula-stage mouse embryos by using antibody against insulin receptors 
and on one morula-stage mouse embryo by using antibody against EGF receptors. 
Preimplantation embryos secret a number of factors and molecules which may be 
related to their viability. Ultra-sensitive detection of these factors (such as insulin growth 
factor and EGF factor) and molecules (such as IL-6) may potentially contribute to animal 
husbandry by increasing the success rate of embryo transfer and contribute to basic 
science by leaning more about gene expression. 
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